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ABSTRACT
Red blood cells (RBCs) are essential for human health, and defects in RBC
development and death give rise to various disorders including anaemia and
erythrocytosis. Mature RBCs or erythrocytes contain high amounts of adenosine 5’triphosphate (ATP) which can be release under various physiological and
pathophysiological conditions. Once released, ATP triggers the activation of
purinergic P2 receptors in an autocrine or paracrine fashion. The P2X7 receptor is a
ligand-gated ion channel belonging to the P2X receptor family. P2X7 activation
induces a number of downstream effects including reactive oxygen species (ROS)
formation and cell death. P2X7 is predominantly expressed on haematopoietic cells
including RBCs. However, the physiological and pathophysiological roles of P2X7
on RBCs remain poorly defined. Recent works from our laboratory have identified
the presence of P2X7 on an immature RBC model, murine erythroleukemia (MEL)
cells. Activation of P2X7 in this cell line induces ethidium+ uptake,
phosphatidylserine exposure, and cell death. This study aims to 1) to determine if
activation of P2X7 induces ROS formation in MEL cells; 2) to determine the
mechanism(s) of P2X7-induced death of MEL cells.

RT-PCR confirmed the presence of P2X7 in MEL cells. Cytofluorometric cation
uptake assay confirmed the function of P2X7 in MEL cells. ATP induced the uptake
of ethidium+ and Yo-Pro-12+ in MEL cells, and this uptake was blocked by the P2X7
antagonist, A-438079. A cytofluorometric assay using the ROS sensitive probe 2’,
7’-dichlorodihydrofluorescein diacetate demonstrated that ATP induced ROS
i

formation in MEL cells in a time- and concentration-dependent fashion with an EC50
of ~150 μM. The most potent P2X7 agonist 3’-O-(4-benzoyl)benzoyl-adenosine 5’triphosphate, but not adenosine 5’-diphosphate or uridine 5’-triphosphate, also
induced ROS formation. Moreover, ATP-induced ROS formation was impaired by
the P2X7 antagonist, A-438079. ATP-induced ROS formation was impaired by the
broad

spectrum

ROS

inhibitors,

N-acetyl-l-cysteine

(NAC)

and

diphenyleneiodonium (DPI), and the mitochondrial complex I inhibitor, rotenone,
but not by the NADPH oxidase inhibitor, apocynin. None of these compounds
impaired ATP-induced ethidium+ uptake. Finally, ATP-induced ROS formation was
not dependent on extracellular Ca2+ influx or intracellular K+ efflux.

The colourmetric MTT assay indirectly confirmed that ATP impaired MEL cell
growth. Moreover, cytofluorometric measurements of Annexin-V binding and 7aminoactinomycin staining directly confirmed that ATP induced death of MEL cell.
A-438079 impaired ATP-induced cell death in both of these assays. Flow cytometry
also showed that MEL cells pre-treated with ATP were phagocytosed by J774A.1
macrophage and that this process was impaired by incubation of MEL cells with A438079 prior to ATP treatment. ATP-induced death of MEL cells was impaired by
the broad spectrum caspase inhibitor, Z-VAD-FMK and mitogen-activated protein
kinase (MAPK) p38 inhibitors, SB202190 and SB203580. None of these compounds
impaired ATP-induced ethidium+ uptake. Moreover, a cytofluorometric assay and
phospho-immunoblotting demonstrated that ATP induced caspase and p38 MAPK
activation in MEL cells respectively, and that these processes were impaired by A438079. In contrast, NAC did not impair the ATP-induced death of MEL cells.
ii

In conclusion, activation of P2X7 induces ROS formation via a mitochondrial
pathway that is independent of extracellular Ca2+ influx and K+ efflux. Moreover,
P2X7 induces death of MEL cells, which can result in their phagocytosis by J774A.1
macrophages. Finally, P2X7 induced MEL cell death is mediated by apoptotic
pathways involving p38 MAPK and caspases, but not ROS formation. This study
supports a role of P2X7 in RBC development and homeostasis.
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1 GENERAL INTRODUCTION
1.1 Red blood cells
1.1.1

Red blood cells and diseases

Mature red blood cells (RBCs) or erythrocytes are biconcave discs devoid of a
nucleus, mitochondria and other internal organelles (Klinken 2002). Erythrocytes are
essential for transporting O2 and CO2 throughout the body and regulating vascular
tone (Ellsworth et al. 2009). The erythrocyte bilayer membrane is composed of
protein, lipid and carbohydrate. More than 95% of cytoplasmic protein is
hemoglobin, which is crucial for gaseous exchange by the erythrocytes.

Defects in erythrocytes result in a number of haematological disorders. The most
common disorders associated with RBCs are the anaemias, characterized by a
decrease in erythrocyte number or haemoglobin concentration, which are caused by
impaired erythropoiesis, increased erythrocyte destruction, decreased haemoglobin
synthesis or combination of these (Means Jr. 1999). In contrast, the overproduction
of RBCs causes erythrocytosis (Prchal and Sokol 1996).
1.1.2

Life cycle of red blood cells

RBCs are produced from haemopoietic stem cells originating from the bone marrow.
RBCs proliferate and differentiate through a series of stages, consisting of progenitor
cells, proerythroblasts, erythroblasts, reticulocytes then eventually erythrocytes. This
process (erythropoiesis) is tightly regulated by the primary hormone, erythroprotein
1

(Klinken 2002). Human RBCs have a life-span of approximately 120 days after
which senescent RBCs are removed from the circulation by the spleen and liver. The
process of programmed death of RBCs (eryptosis) is characterized by cell shrinkage,
membrane blebbing, activation of proteases, phosphatidylserine (PS) exposure on the
outer membrane leaflet and haemolysis. Exposed PS is recognized by macrophages
and subsequently phagocytosed (Bratosin et al. 2001; Lang et al. 2008). Eryptosis is
similar to apoptosis of nucleated cell (Foeller et al. 2008). Defect in eryptosis lead to
development of anemia or erythrocytosis (Klinken 2002).
1.1.3

Murine reticulocyte-like erythroleukemia cells

Murine erythroleukemia (MEL) cells originate from virus-transformed spleen
hematopoietic cells, which grow in suspension cultures and differentiate into
terminally differentiated orthochromatophilic erythroblasts following activation by a
variety of compounds including dimethyl sulfoxide (Friend et al. 1971). MEL cells
have been extensively used as a model of immature RBCs and RBCs (Tsiftsoglou et
al. 2003).
1.1.4

Red blood cells and ATP release

Erythrocytes contain high levels of adenosine 5’-triphosphate (ATP) that are
produced primarily by membrane-bound glycolytic pathways. Erythrocytes release
ATP upon various physiological stimuli including decreased oxygen tension, sheerstress, hypoxia and hypercapnia and infection (Bergfeld and Forrester 1992;
Subasinghe and Spence 2008; Wan et al. 2008). The ATP release pathway involves
the activity of heterotrimeric G proteins Gs and Gi and the adenylyl cyclase, cycle
2

adenosine 5’-monophosphat (cAMP) and protein kinase A activity (Olearczyk et al.
2001; Sprague et al. 2002; Olearczyk et al. 2004; Sprague et al. 2006). ATP release
also involves the cystic fibrosis transmembrane conductance regulator (Sprague et
al. 1998). However, the gap junction protein, pannexin-1, has recently been
suggested to have a role in ATP release from erythrocytes (Locove et al. 2006). In
erythrocytes, pannexin-1 forms a mechanosensitive ATP-permeable channel that
mediates osmotic-induced ATP release (Bao et al. 2004). Once released,
extracellular ATP can interact with purinergic P2 receptors present on the
endothelium to elicit both endothelium-dependent and smooth muscle cell-dependent
vasoactive responses, result in relaxation and dilation (Ellsworth et al. 2009). Apart
from physiological ATP release from erythrocytes, lysis of erythrocytes provides
another mechanism of extracellular ATP, which may activate P2 receptor on
leukocytes. For example, ATP released from lysed erythrocytes is sufficient to
activate P2X7 receptor on murine T cells (Scheuplein et al. 2009).

1.2 P2 receptor on red blood cells
1.2.1

P2X and P2Y receptors

Purinoceptors are classified as P1 purinoceptors, which are activated most potently
by adenosine and P2 purinoceptors which are activated preferentially by ATP or
other nucleotides. P2 receptors can be sub-divided into P2X and P2Y receptors,
which are trimeric ligand-gated ion channels and G protein-coupled receptors,
respectively. (Burnstock 2008).

3

Figure 1-1 Extracellular nucleotide signaling via P2X and P2Y receptor. Schemtric
structure of P2X (Left) and P2Y (Right) receptor are shown. Adenosine 5’triphosphate (ATP) is converted to adenosine 5’-diphosphate (ADP) as well as
adenosine 5’-monophosphate (AMP) and adenosine (not shown) by ecto-enzymes.
ATP acts on P2X and some P2Y receptors; most P2Y receptors are activated by
either ADP, uridine 5’-triphosphate (UTP) or uridine 5’-triphosphate-glucose (UDPglucose).
The P2X receptor family consists of seven subunits, which assemble as homomeric
or heteromeric trimeric channels. Each subunit has two hydrophobic transmembrane
domains, an extracellular loop and intracellular amino and carboxy terminus (Khakh
and North 2006) (Fig.1-1). P2X receptors are selectively permeable to cations (Ca2+,
Na+ and K+) with each subunit displaying unique pharmacological profile (Table 11). The influx of extracellular Ca2+ through these channels constitutes a significant
source of increase in intracellular Ca2+. However, membrane depolarization leads to
the secondary activation of voltage-dependent Ca2+ channels, which probably makes
the major contribution to Ca2+ influx and to the increase in intracellular Ca2+. Unlike
signal transduction pathways which utilize G-protein coupled receptors, this
transduction mechanism does not depend on the production and diffusion of second
4

Table 1-1 General nomenclature and pharmacology of P2 receptorsa
Receptor Rank Order of Agonist Activityb
Antagonistsb
Subtype
NF449,
MRS2220

P2X1

2-meSATP > ATP > α,β-meATP

P2X2

2-meSATP > ATP
α,β-meATP inactive

PPADS

P2X3

2-meSATP > ATP > α,β-meATP

RO-3, Spinorphin

P2X4

ATP > 2-meSATP > α,β-meATP

5-BDBD

P2X5

ATP > 2-meSATP > ADP

none

P2X6

ATP > 2-meSATP > ADP

none

P2X7

BzATP > ATP > 2-meSATP > ADP

KN-62, OxATP,
AZ 10606120,
A438790

P2Y1

2-MeSADP > ADP > 2-meSATP >ATP

MRS2500,
MRS2179

UTP inactive
P2Y2

4-thioUTP > UTP = ATP >> 2-meSATP
ADP, UDP inactive

Suramin

P2Y4

UTP = UDP > GTP = ATP
UDP, ADP inactive

Reactive blue-2

P2Y6

UDP >> UTP > ADP, ATP inactive

MRS2578

P2Y11

ATP = 2-meSATP > ADP

NF 157

P2Y12

2-MeSADP > ADP

ATP, AR-C
69931

P2Y13

ADP > ATP >> UDP, UTP

MRS 2211

P2Y14
UDP-glucose >> UTP, ATP, UDP, ADP
18q
a Table modified from (Gu 2003), (Guay et al. 2011) and Tocris data
b Abbreviations: α,β-meATP: α,β-methylene adenosine 5’-triphosphate; 2-meSATP:
2-methylthio- adenosine 5’-triphosphate; ADP: adenosine 5’-diphosphate; BzATP:
3’-O-(4-benzoyl)benzoyl-adenosine 5’-triphosphate; OxATP: adenosine 5’triphosphate-2’,3’-dialdehyde; UDP: uridine 5’-diphosphate; UTP: uridine 5’triphosphate
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messengers within the cytosol or cell membrane, thus the response time is therefore
very rapid (North 2002). Progressive dilation of the ion-conducting pathway during
prolonged activation by ATP (> 30s) is a further characteristic of some P2X
receptors, especially P2X7 (North 2002). This feature of P2X7 is further discussed in
Section 1.3.

The P2Y receptor family consists of eight members, which under certain conditions
may form homo- and hetero-multimeric assemblies (Burnstock 2008). P2Y receptors,
common as other G protein coupled receptor, have seven hydrophobic
transmembrane domains with an extracellular N-terminus and a cytoplasmic
carboxyl terminal. The transmembrane domains are connected by three extracellular
and three cytoplasmic hydrophilic loops of unequal size (Burnstock 2008) (Fig.1-1).
As for P2X receptor, each P2Y receptor displays a unique pharmacological profile
(Table 1-1). Each P2Y receptor binds to a single heterotrimeric G protein. The
signalling pathway common to most P2Y receptors is the activation of the
phospholipase C (PLC)-inositol trisphosphate (IP3) pathway, which leads to a rise in
both of diacylglycerol (DAG) and cytosolic Ca2+. This stimulates a variety of
signalling pathways including protein kinase C, nitric oxide synthase and subsequent
endothelium-derived relaxing factor formation (Burnstock 2008). P2Y receptors can
also couple positively or negatively to adenylate cyclase to alter cAMP levels,
respectively (Burnstock 2008). In addition, the activation of several P2Y receptors is
commonly associated with the stimulation of several mitogen-activated protein
kinases (MAPKs), in particular extracellular signal-regulated protein kinase 1/2
(Nicholas et al. 1996; Sabala et al. 2001).
6

P2X and P2Y receptors have wide cellular distributions. P2 receptors are expressed
in neural cells, glial cells, epithelia, endothelia, skeletal muscle cells, and
haemopoietic cells (Burnstock and Knight 2004). Activation of these P2 receptors
induces a wide range of cell responses, such as neurotransmission, endocrine and
exocrine secretion, and endothelial-mediated vasodilatation, platelet aggregation,
immune and inflammation responses as well as cell proliferation and cell death
(Burnstock and Knight 2004) .
1.2.2

Expression of P2 receptors on red blood cells

RBCs from a number of species express various P2 receptors (Table 1-2). The
distribution of P2X receptors on mammalian RBCs is well established through
pharmacological studies and the detection of mRNA or protein. In contrast, the
distribution of P2Y receptors on mammalian RBCs is mainly limited to
pharmacological studies. Moreover, the distribution of P2 receptors in nonmammalian RBCs is restricted to pharmacological studies, however study in this area
is limited by the lack of specific P2 antibodies and antagonists, and published gene
sequences.

It is well established that mammalian RBCs express functional P2X7 receptors.
Parker and Snow (1972) and others (Elford 1975; Romualdez et al. 1976) originally
demonstrated that ATP increased the permeability of canine erythrocytes to Na+ and

7

Table 1-2 The presence of P2 receptor in red blood cells
P2 subunit
P2X1,4
P2X2

Speciesa
Human
reticulocytes
Human

Expressionb

-

Hoffman et al. 2004; Wang et al. 2005

IB, IHC

-

Sluyter et al. 2004

-

Human

IB, IHC

Human
reticulocytes

RT-PCR

Canine

IB, IHC

MEL

IB

Murine

IB

Rat
P2X

Lizard

P2Y1

Human
Murine
erythroblasts
Turkey

References

RT-PCR

Mudpuppy
P2X7

Functionb

-

2+

Cell swelling; Ca flux

Light et al.1999; 2003

Cation flux; PS exposure; pore
formation

Sluyter et al. 2004, 2007b; Hoffman et al. 2004;
Wang et al. 2005, Shemon et al.2008, Skalsa et al.2009

-

Hoffman et al.2004

Cation flux; haemolysis; pore
formation

Parker and Snow 1972; Elford 1975; Romualdez et
al.1976; Sluyter et al.2007a; Stevenson et al.2009

PS exposure; MP release; cell
death
Haemolysis

Skalsa et al. 2009

EET release

Jiang et al. 2007

2+

Chatawala and Cantley 1984; Constantinescu 2008

Ca flux

Beraldo et al. 2001, 2007

IB, RT-PCR

Osmolyte permeability

Hoffman et al. 2004; Tanneur et al. 2006

RT-PCR

iCa2+ release

Paredes-Gamero et al. 2006

PLCβ/IP3; iCa2+ release

Berrie et al. 1989; Boyer et al. 1989; Sak et al. 2000

-
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Table 1-1 continued
P2Y2

Human

P2Y4

Lizard

P2Y12
P2Y13

Murine
erythroblasts
Human

RT-PCR, IHC

Wang et al. 2005;Paredes-Gamero et al. 2006;
Sluyter unpublished work
Beraldo et al. 2001,2002; Sartorello and Garcia
2005

iCa2+ release

RT-PCR
RT-PCR

-

Paredes-Gamero et al. 2006

ATP Release

Wang et al. 2005

a Erythrocytes whereas indicated
b Abbreviations: IB, immunoblotting; IHC, immunohitochemistry; cation flux, Na+ and K+ fluxes; PS, phosphatidylserine;
MP, microparticle; EET: epoxyeicosatrienoic acids; PLC, phospholipase C; IP3, inositol trisphosphate.
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K+. Similarly, Chatawala and Cantley (1984) observed that ATP induced Ca2+, Na+
and K+ fluxes in, and impaired the growth of MEL cells. In each of these studies
ATP mediated its effects in a manner characteristic of P2X7; however a role for a P2
receptor in these processes was not considered at the time. Subsequently work from
our group using immunohistochemistry and immunoblotting demonstrated that both
human and canine erythrocytes express P2X7 (Sluyter et al. 2004; Sluyter et al.
2007a; Stevenson et al. 2009). Moreover, cation flux measurements demonstrated
that these cells express functional P2X7, with the relative amount of functional P2X7
being 100-fold higher on canine compared with human erythrocytes; which
paralleled differences in the amount of P2X7 observed by immunoblotting (Sluyter et
al. 2007a; Stevenson et al. 2009). The physiological explanation for this difference
however remains unknown. The presence of P2X7 in RBCs was confirmed by the
detection of P2X7 mRNA transcripts in human reticulocytes and erythrocytes
(Hoffman et al. 2004; Wang et al. 2005). Moreover, functional P2X7 is present in
rat, murine and equine erythrocytes (Jiang et al. 2006; Skalsa et al. 2009), Finally,
our group has confirmed using, immunohistochemistry, immunoblotting and
ethidium+ uptake measurements that MEL cells also express functional P2X7
(Constantinescu, 2008).2008). The mechanisms by which P2X7 induces RBC death
and other downstream signalling events however remains unknown.

RBCs also express functional P2X1 receptors, and possibly P2X2 and P2X4. P2X1
and P2X4 mRNA transcripts are present in human reticulocytes and erythrocytes
(Hoffmann et al. 2004; Wang et al. 2005), while the presence of P2X1 in murine and
human erythrocytes has been confirmed by immunoblotting (Skals et al. 2009).
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Direct evidence for functional P2X4 in these cells is lacking. In contrast, the use of
specific P2X antagonists indicates a role for P2X1 activation, in additional to P2X7
activation, in the α-hemolysin-induced haemolysis of murine and human erythrocytes
(Skals et al. 2009). Immunohistochemistry has also demonstrated the presence of
P2X2 in human erythrocytes (Sluyter et al. 2004), but direct evidence for functional
P2X2 in these cells is lacking. ATP, however, stimulates a regulatory volume
decrease, which reverses the hypotonic swelling of Necturus (mudpuppy) but not
human erythrocytes via a receptor characteristic of P2X2 (Light et al. 1999; Light et
al. 2003).

RBCs express functional P2Y1 receptors. Boyer et al. (1989) and Berrie et al. (1989)
originally describe that ATP, ADP and other P2Y agonists stimulated PLC activation
and subsequent IP3 formation in turkey erythrocytes. P2Y1 has been further
identified the presence in turkey erythrocytes by statistical analysis of the available
pharmacological parameters of several purinoceptor agonists and antagonists in the
turkey erythrocytes (Sak 2000). The presence of P2Y1 on RBCs was confirmed by
detection of P2Y1 mRNA and proteins in the murine erythroblasts and human
erythrocytes, respectively (Paredes-Gamero et al. 2006; Tanneur et al. 2006).
Moreover, P2Y1 activation induces iCa2+ release in murine erythrocytes, and
opening an organic osmolyte and anion permeability pathway in malaria-infected
human erythrocytes (Tanneur et al. 2006).

RBCs express functional P2Y13 receptors. High amounts of P2X7 mRNA transcripts
are present in human reticulocytes and erythrocytes (Wang et al. 2005). P2Y13
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functions as a negative feedback pathway for ATP release from human erythrocytes
(Wang et al. 2005) and plays a role in erythrocyte-associated vascular tone (Section
1.1.4). Wang and colleagues demonstrated that the activation of P2Y13 by ADP
inhibits cAMP and subsequently decreases ATP release from human erythrocytes.
Moreover, ATP and ADP are degraded by ectonucleotidases to adenosine, which is
quickly taken up in the RBCs where it can be recycled to ATP by the glycolytic
pathway (Wang et al. 2005). Thus, ADP may control ATP levels outside the RBC by
inhibition of intracellular cAMP levels via activation of P2Y13 receptors. The
described negative feedback pathway may be important to avoid high extracellular
concentrations of ATP. In contrast, Locove et al. (2006) proposed that the coexpression of P2Y receptors and pannexin-1 channels could mediate ATP-induced
ATP release from RBCs, however there is no direct experimental evidence nor did
they identify the specific P2Y receptor involved to support this proposal.

Reptile (lizard) RBCs express a functional P2Y receptor characteristic of P2Y4
(Sartorello and Garcia 2005), P2Y4 however appears to be absent from mammalian
RBCs, as mRNA for this receptor is absent from human RBCs (Wang et al. 2005)
and murine erythroblasts (Paredes-Garmero et al. 2006). Although the physiological
role of P2Y4-like receptor in lizard RBCs is unknown, ATP triggers a rapid and
transient increase of intracellular Ca2+ by mobilization of the Ca2+ from internal
stores (Beraldo et al. 2001; Sartorello and Garcia 2005). Lizard RBCs also express a
functional P2X receptor (Beraldo and Garcia 2007), however the identity remains
unknown.
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RBCs may also express P2Y2 and P2Y12 receptors, however function evidence is
lacking. Both human reticulocytes and murine erythroblasts express P2Y2 and
P2Y12 mRNA transcripts (Paredes-Garmero et al. 2006; Wang et al. 2005).
Moreover, immunohistochemistry has demonstrated the presence of P2Y2 in a subpopulation of human erythrocytes (Sluyter, unpublished).

1.3 P2X7 receptor
1.3.1

Introduction to the P2X7 receptor

The P2X7 has attracted considerable interest because of its unique biological
properties. In contrast to other P2X receptors, P2X7 has a large carboxyl terminus
with an extra 200 amino acid residues compared with the other receptors. The
carboxyl terminus of the P2X7 is important for modulating P2X7 expression and
function (Costa-Junior et al. 2011). Similar to other P2X receptors, activation of
P2X7 by ATP results in the opening of a non-selective cationic channel, allowing the
rapid influx of Ca2+ and Na+, and efflux of K+. However, upon prolonged stimulation
(>30s), the P2X7 forms an aqueous pore that allows the passage of organic cations
up to 900 Da, such as choline+ and the fluorescent dyes ethidium+ and Yo-Pro-12+
(North 2002). In mice, nicotinamide adenine dinucleotide (NAD) is an alternative
agonist of P2X7 activation, a process which involves ADP ribosylation. This
pathway was initially shown for murine T cells which express ADPribosyltransferase, ART2, that catalyzes ADP ribosylation of P2X7 using NAD as a
substrate (Seman et al. 2003). However, research from our group showed that 300
µM NAD+ failed to induce ethidium uptake into MEL cells (Constantinescu and
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Sluyter, unpublished) despite observing that NAD+ induced ethidium+ uptake into
murine T cells (Stevenson et al. 2009).

P2X7 receptors are widely expressed in cells of haematopoietic lineages, as well as
osteoblasts, fibroblasts, endothelial cells, epithelial cells and neural cells (Sluyter and
Stokes 2011). P2X7 activation induces a number of downstream signaling events.
The best characterized signaling downstream event of P2X7 activation is mediating
the processing and release of mature, biologically active interleukin (IL)-1β and IL18 (Di Virgilio 2007). P2X7 activation can also induces metalloprotease-mediated
shedding of CD62L (L-selectin) and CD23 (low affinity IgE receptor) from the cell
surface (Gu et al. 1998). P2X7 activation can induce the killing of intracellular
pathogen (Coutinho-Silva et al. 2009). Finally, P2X7 activation can induce other
signaling downstream events including, PS exposure, plasma membrane blebbing,
release of microvesicle release as well as reactive oxygen and nitrogen species
formation and cell death (Adinolfi et al. 2005; Hewinson and Mackenzie 2007; Qu
and Dubyak 2009)
1.3.2

P2X7 –induced reactive oxygen species formation

Reactive oxygen species (ROS) are oxygen-derived small molecules, including the
superoxide anion radical (O2−), hydrogen peroxide (H2O2) and the highly reactive
hydroxyl radical (•OH). The physiological generation of ROS can occur as byproducts of cellular metabolism of mitochondrial electron transport chain,
peroxisomes and oxidoreductase, or by the cell membrane complex NADPH oxidase
(Turrens 2003). ROS maintain an integral role in host defense, regulation of
14

apoptosis and cell growth, differentiation and migration, and modulation of cell
signaling. In contrast, excess ROS production can cause tissue damage by reacting
with membrane lipids, DNA and proteins, each of which can have implications in
various clinical conditions including anemia (Simon et al. 2000; Forman and Torres
2002; Waris and Ahsan 2006; Çimen 2008; West et al. 2011).

Mitochondria are the major sources of cellular ROS formation. Several sites of
mitochondrial source of ROS formation exist along the electron transport respiration
chain including respiratory complexes I, II and III (Fig.1-2) (Chen et al. 2003). These
redox centres in the electron transport chain leak electrons to O2, reducing this
molecule to O2−. Dismutation of O2− by superoxide dismutases produces hydrogen
peroxide (H2O2), the main form of ROS (Turrens 2003).

Figure 1-2. Sites of ROS formation in the mitochondrial electron transport chain.
Respiratory complexes I, II and III leak electrons to oxygen (O2) producing the
superoxide anion (O2−). This species may be converted to hydrogen peroxide (H2O2)
and O2 (in both the matrix and the intermembrane space). Figure modified from
(Turrens 2003).
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Several factors induce ROS formation. Excess ROS are produced by exposure to
ionizing and ultraviolet radiation, and during the metabolism of a wide spectrum of
drugs and xenobiotics. Antioxidant enzyme systems exist to neutralize ROS, these
include superoxide dismutases, glutathione peroxidases and catalase (Turrens 2003).
Under normal conditions there is a critical balance between basal ROS formation and
antioxidants. Oxidative stress occurs when this balance is disrupted because of
excess ROS formation, defects in antioxidants, or both (Turrens 2003). Mitochondria
function and intramitochondria Ca2+ play an important role in ROS formation.
(Brookes et al. 2004; Feissner et al. 2009). The underlying mechanism is still unclear,
however, experimental evidence indicate that overloaded mitochondrial Ca2+ leads
ROS formation. Theoretically, increasing Ca2+ would enhance the mitochondrial
metabolic rate, resulting in increased respiratory chain electron leakage and
subsequent ROS formation. Ca2+ can also stimulate activity of nitric oxide synthase
to generate NO-, which inhibits complex IV, and enhance ROS formation. Finally,
Ca2+ can enhance cytochrome c dislocation from the mitochondrial inner membrane,
blocking respiratory chain at complex III, and enhancing ROS formation (Chen et al.
2003).

In addition to mitochondria, NADPH oxidases are also the main sites of ROS
formation. NADPH oxidases are cell membrane enzyme complexes specifically
dedicated to ROS production. The structure of NADPH oxidase consists of several
subunits (Fig.1-3). Upon assembly of these subunits in the membrane, this enzyme
via its subunit NOX2 (gp91phox ) generates a burst of O2- on the extracellular side of
the membrane by one-electron reduction of O2 (Dusting et al. 2005). NADPH
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oxidase proteins are present in a variety of cells and tissue and are thought to play
specific roles of ROS production (Bedard and Krause 2007). As for mitochondrial
ROSformation, NADPH oxidase-derived ROS formation requires the antioxidant
enzyme systems to avoid excess ROS formation.

Figure 1-3. NADPH oxidase-derived ROS formation. NADPH oxidase complex
consists of cytosolic subunits p47phox, p40phox and p67phox, two cell membrane bound
subunits NOX2 (gp91phox) and p22phox, and a small G protein Rac. O2- is producd on
the extracellular side of the membrane by one-electron reduction of O2 via the NOX2
subunit, using reduced NADPH as the electron donor. Figure modified from (Dusting
et al. 2005)
P2X7 induces ROS formation in a variety of immune and non-immune cells to
participate in P2X7-induced pro-inflammatory cytokine release and cell death
(Hewinson and Mackenzie 2007). The involvement of P2X7 activation in ATP
mediated ROS generation has been largely demonstrated by pharmacological
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approaches in human neutrophils (Suh et al. 2001), murine macrophages (Moor et al.
2009, Noguchi et al. 2008), rat microglia (Parvathenani et al. 2003), human
eosinophils (Ferrari et al. 2000), and rat and mouse submandibular cells (Seil et al.
2008; Fontanils et al. 2010). The role of P2X7 activation in ROS formation is further
supported by comparison of ATP-induced responses in a murine macrophage cell
line deficient in P2X7 with the P2X7-expressing RAW264.7 line (Pfeiffer et al.
2007).

The NADPH oxidase plays a dominant role in P2X7-induced ROS formation in
macrophages and microglia (Hewinson and Mackenzie 2007). This conclusion is
primarily based on the use of pharmacological inhibitors of the NADPH oxidase.
However, Noguchi et al. (2008) and Moor et al. (2009) used NOX2 knockout mice
to support the role of the NADPH oxidase in P2X7-induced ROS formation in
macrophages. Moreover, stimulation of microglia with the most potent P2X7 agonist,
BzATP triggers the translocation of p67phox to the plasma membrane, which is a
critical step in the activation of the NADPH oxidase (Parvathenani et al. 2003). In
contrast to the NADPH oxidases, there is little evidence for a role for P2X7 in
mitochondrial ROS formation. P2X7-induced ROS formation, however, is impaired
by a mitochondria complex I inhibitor in murine bone marrow-derived macrophages,
but not in J774 macrophages (Moore et al. 2009). Thus, NADPH oxidase appears to
be the major mechanism for P2X7-induced ROS formation.

In addition to the NADPH oxidase, Ca2+ influx also may be important for P2X7induced ROS formation. Removal of extracellular Ca2+ reduces P2X7-induced ROS
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formation in murine macrophages (Guadalupe et al. 2010), murine microglia
(Parvathenani et al. 2003) and rat submandibular cells(Fontanils et al. 2010). In
contrast, P2X7-induced ROS in mouse submandibular cells is independent of
extracellular Ca2+ (Seil et al. 2008), indicating that the effect of Ca2+ is cell and/or
species specific, or that multiple pathways exist.
1.3.3

P2X7-induced cell death

Cell death plays an important role in the development and homeostasis of
multicellular organisms (Krysko et al. 2008). According to the Nomenclature
Committee on Cell Death (NCCD) (Kroemer et al. 2009), types of cell death can be
classified as: apoptosis (type I), cell death associated with autophagy (type II),
necrosis or oncosis (type III). Cells undergoing apoptosis show typical, well-defined
morphological changes, including, cell shrinkage, plasma membrane blebbing, lost
plasma integrity, chromatin condensation, DNA fragmentation and formation of
apoptotic bodies (Krysko et al. 2008). Apoptosis has also been characterized by
several biochemical criteria, including PS exposure on the outer leaflet of the plasma
membrane, changes in mitochondrial membrane permeability, caspase activation and
cytochrome c and bc1 release. In contrast, necrosis is characterized by rapid
cytoplasmic swelling, cell lysis, breakdown and release of intracellular organelles,
and a lack of caspase activation. The final fate of almost dying/dead cells regardless
of death type is engulfment by phagocytes. In the absence of phagocytosis, apoptotic
cells proceed to a stage called secondary necrosis, which shares many features of
primary necrosis (Krysko et al. 2008).

19

Various methods have been developed to detect cell death. The most convenient
technique to study cell death on a per-cell basis is the combined use of fluorochrome
conjugated Annexin-V and with exclusive dye such as propidium iodide or 7aminoactinomycin (7AAD) (Krysko et al. 2008).

Colourimetric assays, such as the lactate dehydrogenase (LDH) release and thiazolyl
blue tetrazolium bromide (MTT) assays are relatively economical methods to
measure cell death. The LDH release assay assesses the activity of LDH in culture
supernatants released from cytoplasm following cells lysis. The MTT assay measures
the mitochondrial metabolical activity as an indicator of the number of viable cells,
and hence can measure cell death or proliferation (Kroemer et al. 2009).

DNA fragmentation is often used to distinguish apoptosis from necrosis. This is often
detected by agarose gel electrophores. However, a more sensitive and quantitative
way is by the terminal deoxynucleotidyl transferase-mediated dUTP nick-end
labeling method and flow cytometry (Krysko et al. 2008).

DNA fragmentation, PS exposure, caspase activation and above morphological
changes are considered to be features of apoptosis. LDH release is a feature of
necrosis. The descriptions of apoptosis or necrosis in studies of cell death remain
poor, which is attributed in part to limited use of experimental parameters. Therefore,
the NCCD recommends “investigators studying cell death to quantify this process
using more than one assay whenever possible” (Kroemer et al. 2009).
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ATP-induced cell death was initially documented in murine lymphocytes (Di
Virgilio et al. 1989; Zanovello et al. 1990) and then extended to a variety of immune
cells, neural cells and epithelial cells as well as RBCs (Table 1-3). The involvement
of P2X7 in ATP-induced cell death has largely been established through the use of
P2X7 agonists and antagonists. However, a role for this receptor in this process has
been confirmed by use of cells from P2X7 knockout mice (Le Feuvre et al. 2002)
and subjects coding loss-of-function P2X7 polymorphisms (Gu et al. 2001; Fernando
et al. 2005). P2X7-induced cell death can be initialized by either spontaneous or
stimulated ATP release through an autocrine or paracrine loop (Chiozzi et al. 1997).
For example, basal ATP release induced the spontaneous death of murine
macrophages which was significantly reduced by incubation with P2X7 antagonists
or the ATP-hydrolyzing enzyme apyrase. NAD+ can also induce death of murine T
cells at lower concentration, compared to ATP (Seman et al. 2003). However,
whether P2X7 induces cell death differ in each study is mediated by apoptosis or
necrosis remains controversial.

Di Virgilio et al. (1998) suggested that the type of cell death induced by P2X7
contribution depends upon the ATP incubation time or concentration, and/or cell
type. Moreover, the mechanisms by which P2X7 activation induces either apoptosis
or necrosis, and the cells involved varies (Table 1-3), with the pathways involved
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Table 1-3 P2X7 activation induces cell death in different cell types
Cell type
P-815 mastocytoma
YAC lymphoma cells
Thymocytes

Detection hallmarks

Signal transduction

DNA fragmentation; Cr51 release
MC; PS exposure/PI

Mitochondria; ceramide
-

Di Virgilio et al. 1989
Zanovello et al. 1990
Lépine et al. 2006, Pizzo et al. 1991

T cells

MC; LDH release

Lymphocytes

7AAD

-

Gu et al. 2001

Monocytes/macrophages

PS exposure/PI

-

Peritonel macrophages

LDH release; MC

Fernando et al. 2005
Le Feuvre et al. 2001;Costa-Junior et
al.2009

BMDMs
J774A.1 macrophages

LDH release

Cl ; ERK

References

Tsukimoto et al. 2006

Caspase-1; iPLA; LOX-5
Caspase-1
ROS; caspase-1; cathepsin
JNK; Caspase-1/3

Moore et al. 2007

BAC1.2F5 macrophages

LDH release; DNA fragmentation

Humphreys et al. 2000

RAW 264.7 macrophages

LDH release; DNA fragmentation;
PLD; ROS; ASK1,
PS exposure/PI

Spleen dendritic cells

MC; PI; DNA fragmentation

BMDMs

PS exposure/PI

Cervical epithelial cells

DNA fragmentation; caspase
activation

Caspase-3/9; Ca2+

Wang et al. 2004

Neoplastic cells

DNA fragmentation

Caspase-3/9; Ca2+

Fu et al. 2009

Stuff et al. 2007, Noguchi et al. 2008

p38; Caspase-3
-
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Nihei et al. 2000

Table 1-3 continued
N13 microglial

DNA fragmentation; LDH release,
MC

Caspase-1/3/8

Ferrari et al. 2007

Primary cortical neurons

DNA fragmentation; caspase
activation

Caspase-8/9/3; JNK; ERK

Kong et al. 2005

RPMI-8226 myeloid cells

MTT, PS exposure/7AAD

-

Farrell et al. 2010

Erythrocytes

Hb release

-

Sluyter et al. 2007a

MEL cells
P2X7-transfected DT 40
lymphocytes cells

MTT; PS exposure/7AAD

-

Constantinescu 2008

LDH release, MC

Cl-

Tsukimoto et al. 2005

a Abbreviations: 7AAD: 7-aminoactinomycin; BMDMs: Bone Marrow Derived macrophages Hb: haemoglobin; iPLA2:

Calcium-independent-phospholipase; LDH: lactate dehydrogenase; LOX: lipoxygenase; A2; MTT: thiazolyl blue tetrazolium
bromide; MC: Morphological Changes, including, cell shrinkage, chromatin condensation, formation of apoptotic bodies; PI: propidium
iodide; PS: phosphatidylserine
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only partly defined. The best characterised pathways, each representing different cell
types, are outlined below and summarised in Fig.1-4.

One of the best characterised P2X7-induced cell death pathways is described in myeloid
cells. In murine RAW241.7 macrophages, P2X7-induced cell death pathway involves
NADPH oxidase-induced ROS formation following by the activation of

ASK1

activation and MAPK family p38 and the subsequent activation of caspase (Noguchi et
al. 2008) (Fig. 1-4). The involvement of these compounds was established through the
use of pharmacological blockage, as well as RAW264.7cells deficient in NADPH
oxidase subunit, NOX2 and ASK1. However, the role of JNK was excluded in this
pathway. In contrast, Humphreys et al. (2000) revealed that P2X7-induced death of
BAC1 macrophage involves pathways dependent on JNK and caspase-3 activation. In
an early observation, Ferrari et al. (1999) demonstrated that P2X7-induced death of
murine microglia cells involves the caspase-8 and caspase-3 (presumably downstream
of caspase-8), and the subsequent processing of the caspase substrates Poly (ADPribose) polymerase and lamin B. Caspase-1 was
also activated in these cells, however the authors assumed that this was related to IL-1β
processing and not cell death. However, P2X7-induced necrosis (LDH) release is
impaired in murine macrophages from caspase-1 knockout mice (Le Feuvre et al. 2002),
thus a role for caspase-1 in P2X7-induced cell death remains unclear. Nevertheless,
these results confirm that P2X7-induced cell death in various myeloid cells involves
caspase-3.
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Figure 1-4 P2X7-induced cell death in different cell types involves different signalling
pathways. P2X7 activation induces various pathways which culminate in caspase-3
activation and cell death. (Left) P2X7-induced death of macrophage, and possibly
microglia, depends on NADPH oxidase-generated ROS and ASK1-p38 pathway.
(Middle) P2X7-induced death of epithelial cells involves the influx of Ca2+, the
mitochondria and subsequent caspase-9. (Right) P2X7-induced death of neuronal cells
depends on the ERK1/2 and JNK1 pathway and subsequent activation of caspase-8/9.
P2X7-induced cell death has also been described in non-myeloid cells. P2X7-induced
death of epithelial cells is mediated by the mitochondrial apoptotic pathway (Fig. 1-4).
P2X7-induced death of human cervical epithelial cells and murine keratinocytes
requires an influx of Ca2+ and the subsequent activation of caspase-9 and caspase-3
(Wang et al. 2004; Fu et al. 2009). The activation of caspase-9 highly suggests that
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P2X7-induced death of these cells is mediated predominantly by mitochondrial
apoptotic pathway in these cells. Finally, P2X7-induced death of neuronal cells is
mediated by ERK1/2 and JNK1, and the activation of caspase (Fig. 1-4). This pathway
was demonstrated and involved the intrinsic caspase-8/9/3 activation pathway (Kong et
al. 2005). Moreover, mitogen-activated protein kinases family numbers ERK1/2 and
JNK1 up-regulate the P2X7-induced caspase activation in these cells.

1.4 Concluding remarks and aims
RBCs are essential for human health and defects in RBC development and cell death
give rise to various disorders including anaemia and erythrocytosis. The presence of
P2X7 on RBCs suggests a role for this receptor in RBC homeostasis and disorders.
However, the physiological and pathophysiological roles of the P2X7 receptor on RBCs
remain poorly defined. Chatawala and Cantley (1984) observed that extracellular ATP
can induce Ca2+, Na+ and K+ fluxes in, and impair the growth of MEL cells, a model of
immature RBCs. Recently, our group demonstrated that this cell expresses the P2X7,
and activation of this receptor induces ethidium+ uptake and cell death in this cell line
(Constantinescu 2008). Thus, the present study aims 1) to determine if activation of
P2X7 induces ROS formation in MEL cells; 2) to determine the mechanism of P2X7induced cell death of MEL cells.
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2 MATERIALS AND METHODS

2.1 Materials
RPMI-1640 medium, fetal calf serum (heat inactivated before use), L-glutamine,
gentamicin, trypsin, Yo-Pro-12+ , the reactive oxygen species (ROS) detection probe
2’,7’-dichlorodihydrofluorescein diacetate (H2DCFDA) and thiazolyl blue tetrazolium
bromide (MTT) were from Invitrogen (Grand Island, NY). Adenosine 5’-triphosphate
(ATP), 3’-O-(4-benzoyl)benzoyl-adenosine 5’-triphosphate (BzATP), adenosine 5’diphosphate (ADP), uridine 5’-triphosphate (UTP), rotenone, ethylene glycol-bis-(2aminoethyl)-N,N,N',N'-tetraacetic acid (EGTA), PKH-26 Red Fluorescent Cell Linker
Kit and 2-mercaptoethanol were from Sigma (St. Louis, MO). A-438079 was from
Tocris Bioscience (Ellisville, MO). Bovine serum albumin (BSA) and ethidium bromide
were from Amresco (Solon, OH). SB203580 was purchased from Jena Bioscience
(Jena, Germany). N-acetyl-L-cysteine (NAC) and 7-aminoactinomycin D (7AAD) were
from Alexis Biochemicals (Lausen, Switzerland). SB202190 and apocynin were from
Calbiochem (Darmstadt, Germany). Z-VAD-FMK and CaspGLOWTM Fluorescein
Active Caspase Staining Kit were from Biovision (San Diego, CA). Annexin-V-FLUOS
and DNase I were from Roche Diagnostics (Pensberg, Germany). Diphenyleneiodonium
(DPI) was from Cayman Chemical (Ann Arbor, MI). PhosphoPlus® p38 MAPK
(Thr180/Tyr182) Antibody Kit was purchased from Cell Signaling Technology
(Beverley, MA). Amersham Hyperfilm ECL was purchased from GE Healthcare (Little
Chalfont, Buckinghamshire, UK). Nitrocellulose membrane was from Bio-Rad
(Hercules, CA). Other reagent grade chemicals were from Sigma or Amresco (Solon,
OH).
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2.2 Cell culture
RAW264.7 cells were obtained from the American Type Culture Collection (Manassas,
VA). Murine erythroleukemia (MEL) cells were kindly provided by Dr. Sally A. Eaton
(The University of Sydney, Sydney, Australia). The murine macrophage cell line
J774A.1 originally obtained from the American Type Culture Collection (Manassas,
VA), was kindly provided by Ms. Jasmyn Dunn (The University of Queensland,
Brisbane, Australia). All Cells were maintained in complete culture medium (RPMI1640 medium containing 10% fetal calf serum, 5 mM L-glutamine and 5 mg/mL
gentamicin) at 37 °C and 95% air/5% CO2. RAW264.7 cells and J774A.1 cells were
harvested by mechanical scraping.

2.3 Fluorescent cation dye uptake assay
P2X7-induced pore formation was measured to assess the P2X7 function using a fixedtime assay as described (Farrell et al. 2010). Cells (1×106 cells/mL), resuspended in
NaCl medium (145 mM NaCl, 5 mM KCl, 5 mM glucose, 0.1% BSA and 10 mM
HEPES, pH 7.5) or KCl medium (150 mM KCl, 5 mM glucose, 0.1% BSA and 10 mM
HEPES, pH 7.5), were incubated with 25 μM ethidium+ (or 1 μM Yo-Pro-12+ as
indicated) in the absence or presence of nucleotides (as indicated) for 15 min at 37°C.
Incubations were stopped by addition of an equal volume of ice cold NaCl medium
containing 20 mM MgCl2 (MgCl2 medium) and centrifugation (300×g for 5 min). Cells
were washed once with NaCl medium. In some experiments, cells were pre-incubated at
37°C in the absence or presence of 10 μM A-438079 for 15 min, or ROS, caspase and
p38 MARK inhibitors (as indicated) before the addition of ethidium+. In some
experiments, cells were resuspended in NaCl medium containing 1 mM CaCl2 or 100
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μM EGTA before the addition of ethidium+. Since free Ca2+ lowers the concentration of
ATP4-, cells in the presence of 1 mM Ca2+ were incubated with 1.74 mM ATP, to
provide equimolar ATP4-concentrations (251 μM). The ATP4- concentration in solution
was calculated using the Bound and Determined Program (Marks and Maxfield 1991).
Data was collected by using a LSR II flow cytometer (BD Biosciences, San Diego, CA)
and the mean fluorescence intensity (MFI) of ethidium+ or Yo-Pro-12+ uptake
determined using FlowJo software (Tree Star, Ashland, OR).

2.4 Reactive oxygen species formation assay
Nucleotide-induced ROS formation was assessed in MEL cells loaded with the ROSsensitive compound, H2DCFDA, according to manufacturer’s instruction. Cells
resuspended in NaCl medium (1×106 cells/mL) were incubated with 5 μM H2DCFDA
for 5 min at 37°C under limited light conditions. Incubations were stopped by
centrifugation (300×g for 5 min). H2DCFDA-loaded cells, resuspended in NaCl or KCl
medium without BSA were then incubated with in the absence or presence of
nucleotides (as indicated) for 15 min at 37°C. Incubations were stopped by addition of
an equal volume of ice cold MgCl2 medium and centrifugation (300×g for 5 min). Cells
were washed once with NaCl medium. In some experiments, cells were pre-incubated at
37°C in the absence or presence of 10 μM A-438079 for 15 min or various ROS
inhibitors (as indicated) before the addition of nucleotide. In some experiments, cells
were resuspended in NaCl medium containing 1 mM CaCl2 or 100 μM EGTA before
ATP addition. As above (Section 2.2), cells in the presence of 1 mM Ca2+ were
incubated with 1.74 mM ATP, to provide equimolar ATP4-concentrations (251 μM).
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Data was collected by flow cytometry and the MFI of DCF converting from H2DCFDA
determined using FlowJo software.

2.5 Colormetric measurement of cell growth
MEL cell growth was measured using a MTT assay as described (Farrell et al. 2008).
MEL cells (5×105 cells/mL/well) in complete culture medium in 96-well plates were
incubated in the absence or presence of ATP (as indicated) for 24 h at 37°C and 95%
air/5% CO2. During the final 4 h of ATP incubation, 0.5 mg/mL MTT was added (10
μl/well). Cells were then incubated with 10 mM HCl containing 10% SDS
(solubilization solution) (100 μL/well) overnight at 37°C. Absorbances were read at a
wavelength of 550 nm and a reference wavelength of 690 nm using a SpectaMax
Plus384 microplate reader (Molecular Devices, Sunnyvale, CA).

2.6 Cytofluorometric measurement of cell death
MEL cells in complete culture medium in 24-well plates (5×105 cells/mL/well) were
incubated in the absence or presence of 1 mM ATP for 24 h at 37°C and 95% air/5%
CO2. In some experiments, cells were pre-incubated 37°C in the absence or presence of
10 μM A-438079 for 15 min or 20 μM Z-VAD-FMK, SB203580 or SB202190 for 30
min before the addition of ATP. Following 24 h incubation with ATP, cells were
harvested and washed once with NaCl medium containing 5 mM CaCl2. Cells in 100 μl
NaCl medium containing 5 mM CaCl2 were then incubated with Annexin-V-FLUOS
and 7AAD for 15 min at room temperature, before addition of 400 μl NaCl medium
containing 5 mM CaCl2. Data was collected by flow cytometry. Cells were gated to
exclude dust particles and small cellular debris (events of low forward and side scatter),
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and the percentage of Annexin-V+/7AAD-, Annexin-V-/7AAD+ and AnnexinV+/7AAD+ cells within the gate determined using FlowJo software.

2.7 Phagocytosis assay
The phagocytosis of PKH-26-labelled MEL cells by J774A.1 macrophages was adapted
from a previously described method for erythrocytes (Schrijvers et al. 2004), except
MEL cells were labelled with PKH-26 using the manufacturer’s reagents as described
(Healey et al. 2007). Cells (2×107) were washed twice with serum-free RPMI-1640
medium and incubated in 2 mL of 2 μM PKH-26 in Diluent C (as provided) for 5 min at
room temperature with gentle mixing. The reactions were stopped by adding an equal
volume (2 mL) of serum, incubating for 1 min at room temperature, diluting to 10 mL
with complete culture medium and centrifugation (400×g for 10 min). The cells were
washed twice with complete culture medium as above. The labelled cells were then
suspended in complete culture medium, and incubated in 24-well plates in the absence
or presence of 1 mM ATP for 24 h at 37°C and 95% air/5% CO2. The following day,
PKH-26-labeled MEL cells were washed three times and suspended in complete culture
medium. Cells (2×106 cells/mL/well) were then incubated with adherent J774A.1 cells
in a 24-well plate (2×105/mL/well) for 1 h at 37°C and 95% air/5% CO2. The wells were
washed five times with cold PBS (137.9 mM NaCl, 2.7 mM KCl, 1.5 mM KH2PO4 and
8.1 mM Na2HPO4, PH7.2) and incubated with 0.05% trypsin for 5 min to remove semiadherent/non-phagocytosed MEL cells. J774A.1 cells were collected by scraping. Data
was collected by flow cytometry and the cells gated to distinguish the J774A.1 cells and
any remaining MEL cells and the percentages of phagocytosed MEL cells were
determined using FlowJo software.
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2.8 Caspase activation assay
The caspase activation assay was performed using the CaspGLOWTM Fluorescein
Active Caspase Staining Kit according to the manufacturer’s instructions. MEL cells
(5×105 cells/mL/well) in complete culture medium in 24-well plates were incubated in
the absence or presence of 1 mM ATP for 6 h at 37°C and 95% air/5% CO2. In some
experiments, cells were pre-incubated in the absence or presence of 10 μM A-438079
for 15 min at 37°C before the addition of ATP. Following incubation with ATP, 300 μl
of cells were incubated with 1 μl fluorescein isothiocyanate (FITC)-VAD-FMK for 1 h
at 37°C and 95% air/5% CO2. Cells then were harvested, washed twice and suspended
in Wash Buffer (as provided). Data was collected by flow cytometry and the percentage
of caspase activated cells was determined using FlowJo software.

2.9 Immunoblotting analysis
Immunoblotting analysis of the of p38 MAPK and phospho-p38 MAPK
(Thy180/Tyr182) was performed using phosphoPlus p38 MAPK (Thr180/Tyr182)
Antibody Kit according to the manufacturer’s instructions as described (Yu et al. 2010).
The cells (5×105 cells/mL/well) in complete cell culture in 24-well plates were
incubated in the absence or presence of 1 mM ATP for 5 min at 37°C and 95% air/5%
CO2. In some experiments, cells were pre-incubated in the absence or presence of 10
μM A-438079 for 15 min at 37°C before the addition of ATP. Following incubation
with ATP, cells were harvested and placed on ice until centrifuged (16000×g for 5 min
at 4°C). Cells were resuspended in 100 μl ice-cold SDS sample buffer containing 5% 2mercaptoethanol, and then the cells were sonicated in the presence of DNase I
(10µg/mL) for 5 min. The cell lysates were separated by SDS-PAGE (4% stacking gel,
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10% resolving gel) and transferred to nitrocellulose membranes. Nitrocellulose
membranes were blocked overnight at 4°C with Tris-buffered saline (250 mM NaCl,
0.2% Tween-20 and 50 mM Tris, pH 7.5) containing 5% skim milk powder, and then
incubated for 1 h at room temperature with rabbit anti-p38 MAPK or anti-phospho-p38
MAPK antibodies diluted in Tris-buffered saline containing 5% BSA. Membranes were
washed three times over 30 min with Tris buffered saline and then incubated with HRPconjugated anti-rabbit IgG antibody diluted in Tris-buffered saline containing 5% BSA
for 1 h. Membranes were washed as above, incubated with LumiGLO
chemiluminescent (as provided), and visualised using Amersham Hyperfilm ECL.

2.10 Presentation of data and statistics
Results are represented as means ± SD. Data was compared using either the unpaired
Student's t-test for single comparisons or one-way analysis of variance (using Tukey's
post test) for multiple comparisons using Prism 5 for Windows Version 5.01 (GraphPad
Software, San Diego, CA) with P < 0.05 considered significant.
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3 P2X7 ACTIVATION INDUCES MITOCHONDIAL REACTIVE
OXYGEN SPECIES FORMATION IN MURINE
ERYTHROLEUKEMIA CELLS
3.1 Results
3.1.1 P2X7 mRNA is expressed in murine erythroleukemia cells
Previous works from our group (Constantinescu 2008) using immunoblotting and
immunofluorescence staining demonstrated that murine erythroleukemia (MEL) cell
line expresses P2X7 receptor. Thus, to further confirm that MEL cells express P2X7,
mRNA was isolated and amplified by RT-PCR. mRNA from RAW264.7 cells, which
express P2X7 (Cankurtaran-Sayar et al. 2009), were included as a positive control.
P2X7 mRNA was expressed in both cell types (Fig. 3-1).

Figure 3-1 P2X7 mRNA is expressed in MEL cells. RNA was isolated from
RAW264.7 and MEL cells, and analysed by RT-PCR using primers to P2X7. RNA
substituted with H2O was used as a negative control. PCR products were visualised
using ethidium bromide stainning. Results are representative of 3 experiments.

3.1.2 A P2X7 antagonist impairs ATP-induced ethidium+ and Yo-Pro-12+ uptake
Constantinescu (2008) reported that adenosine 5’-triphosphate (ATP) induces ethidum+
uptake into MEL cells and this uptake was impaired by incubation of cells with the
34

P2X7 antagonist A-438079 (Nelson et al. 2006).To confirm these observations, cells
were pre-incubated in the absence (control) or presence of A-438079 (10 μM), before
incubating in the absence (basal) or presence of ATP. As observed previously
(Constantinescu 2008), ATP induced ethidium+ uptake into MEL cells, and this
proccess was significantly impaired by A-438079 (81% ± 7%, Fig.3-2A). To determine
if P2X7 activation could induce the uptake of a second cation, Yo-Pro-12+
(Cankurtaran-Sayar et al. 2009), cells were pre-incubated in the absence or presence of
A-438079, and ATP-induced Yo-Pro-12+ uptake examined as above. As for ethidum+,
ATP induced Yo-Pro-12+ uptake into MEL cells, and pre-incubation with A-438079
significantly impaired this uptake by 79 ± 9% (Fig. 3-2B).

3.1.3

ATP induces reactive species formation in a time- and concentration-dependent
fashion

P2X7 activation induces reactive oxygen species (ROS) formation in various myeloid
cell types (Hewinson and Mackenzie 2007). To determine whether extracellular ATP
can induce ROS formation in MEL cells, cells were loaded with 2’,7’dichlorodihydrofluorescein diacetate (H2DCFDA) which is converted to the highly
fluorescent product 2’,7’-dichlorofluorescein (DCF) by intracellular ROS formation.
Cells were then incubated in the absence (basal) and presence of ATP for up to 30 mins.
ATP (1 mM) induced ROS formation in MEL cells in a time-dependent fashion (Fig.33A). ATP also induced ROS formation in a concentration-dependent fashion with a
maximal response at 2 mM ATP (Fig.3-3B). This ATP concentration response gave an
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EC50 of 153 ± 10 μM, which is similar to the previously determined for ATP-induced
ethidium+ uptake in MEL cells (EC50 154 ± 13 μM) (Constantinescu 2008).

Figure 3-2 A P2X7 antagonist impairs ATP-induced ethidium+ and Yo-Pro-12+ uptake
into MEL cells. MEL cells in NaCl medium were pre-incubated in the absence (control)
or presence of 10 μM A-438079 at 37°C for 15 min, and then with (A) 25 μM
ethidium+ or (B) 1 μM Yo-Pro-12+ were incubated in the absence (basal) or presence of
1 mM ATP at 37°C for 15 min. (A, B) Incubations were stopped by addition of NaCl
medium containing 20 mM MgCl2 (MgCl2 medium) and centrifugation, and the cells
analysed by flow cytometry. Results are mean ± SD (n = 3); **P < 0.01 compared to
corresponding basal; †† P < 0.01 compared to ATP alone.
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Figure 3-3 ATP induces ROS formation in MEL cells. MEL cells were loaded with 5
μM H2DCFDA for 5 min at 37°C in NaCl medium under limited light conditions. After
washing, cells in NaCl medium were incubated in the absence (basal) or presence of (A)
1 mM ATP at 37°C for up to 30 min, or (B) varying ATP concentrations for 15 min. (A,
B) Incubations were stopped by addition of MgCl2 medium and centrifugation, and the
mean fluorescence intensity (MFI) of DCF was determined by flow cytometry. ROS
formation is expressed as (A) MFI or (B) percent maximum response compared to 2
mM ATP. Results are mean ± SD (n = 3); where SDs are not visible, SDs are ≤1.1.
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3.1.4

P2X7 agonists induces reactive oxygen species formation

To determine whether P2X7 activation induces ROS formation in MEL cells, the cells
were incubated in the absence (basal) or presence of the most potent P2X7 agonist 3'-O(4-benzoyl)benzoyl-adenosine 5'-triphosphate (BzATP), but not adenosine 5’diphosphate (ADP) or uridine 5’-triphosphate (UTP) that do not activate P2X7
(Donnelly-Roberts et. al. 2009). ATP was included as a positive control. ATP and
BzATP, but not ADP or UTP, induced ROS formation in MEL cells (Fig.3-4).

Figure 3-4 P2X7 agonists induce ROS formation in MEL cells. H2DCFDA -loaded
MEL cells were incubated in NaCl medium in the absence (basal) or presence of 1 mM
agonist (as indicated, except BzATP, 200 μM) at 37°C for 15 min. Incubations were
stopped by addition of MgCl2 medium and centrifugation, and the cells analysed by
flow cytometry. Results are mean ± SD (n = 3); **P < 0.01 compared to basal.
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3.1.5

A P2X7 antagonist impairs ATP-induced reactive oxygen species formation

To confirm that the ATP-induced ROS formation in MEL cells was mediated by P2X7
activation, cells were pre-incubated in the absence (control) or presence of the P2X7
antagonist A-438079 (10 µM), and then incubated in the absence (basal) or presence of
ATP. As above, ATP induced ROS formation in MEL cells. Pre-incubation with A438079 significantly impaired ATP-induced ROS formation in MEL cells by 87 ± 1%
(Fig.3-5).

Figure 3-5 The P2X7 antagonist impairs ATP-induced ROS formation in MEL cells.
H2DCFDA-loaded MEL cells in NaCl medium were pre-incubated in the absence or
presence of 10 μM A-438079 at 37°C for 15 min, and then incubated in the absence
(basal) or presence of 1 mM ATP at 37°C for 15 min. Incubations were stopped by
addition of MgCl2 medium and centrifugation, and the cells analysed by flow
cytometry. Results are mean ± SD (n = 3); ** P < 0.01 compared to corresponding
basal; †† P < 0.01 compared to ATP alone.
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3.1.6

Mitogen-actived protein kinase p38 inhibitors increased basal P2X7-induced
reactive oxygen species formation

A previous study reported that a p38 MAPK inhibitor, SB203580, impaired P2X7induced ROS formation in primary rat microglia (Parvathenani et al. 2003). To
determine whether the p38 MAPK pathway involves in P2X7-induced ROS formation
in MEL cells. H2DCFDA-loaded cells were pre-incubation in the presence of DMSO
control or p38 MAPK inhibitors, SB202190 and SB203580, before incubation in the
absence (basal) or presence of ATP. Pre-incubation of cells with SB202190 or
SB203580 in the absence of ATP induced significant increases in ROS formation,
compared to basal (Fig.3-6A, B). Pre-incubation of SB202190 and SB203580 failed to
induce a significant decrease of ATP-induced ROS formation. Thus, the effect of the
p38 MAPK inhibitors on ROS formation following ATP could not be assessed due to
the high amount of ROS formation induced by these inhibitors alone (Fig.3-6A, B).
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Figure 3-6 p38 MAPK inhibitors increase basal P2X7-induced ROS formation in MEL
cells. H2DCFDA-loaded MEL cells in NaCl medium were pre-incubation in the
presence of DMSO control and p38 MAPK inhibitors, SB202190 and SB203580 at
37°C for 30 min, and then incubated in the absence (basal) or presence of 1 mM ATP at
37°C for 15 min. Incubations were stopped by addition of MgCl2 medium and
centrifugation, and the cells analysed by flow cytometry. Results are mean ± SD (n = 3);
** P < 0.01 compared to corresponding basal; †† P < 0.01 compared to ATP alone. ‡‡
P < 0.01 compared to basal alone.
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3.1.7

Broad spectrum and mitochondrial complex reactive oxygen species inhibitors
impaired P2X7-induced ROS formation

Several cellular sources contribute to the production of ROS, predominantly the
mitochondrial respiratory chain and NADPH oxidase (Turrens 2003). To determine
which cellular source(s) contribute to ROS formation following P2X7 activation, MEL
cells were pre-incubated in the absence or presence of pharmacological inhibitors of
ROS formation before ATP addition. Pre-incubation of MEL cells with broad spectrum
inhibitors of ROS formation, 10 mM N-acetyl-L-cysteine (NAC) and 20 µM
diphenyleneiodonium (DPI), impaired ATP-induced ROS formation by 70 ± 5% and 51
± 5%, respectively (Fig.3-7A, B). Pre-incubation of MEL cells with 5 µM rotenone, an
inhibitor of mitochondrial complex I (Chen et al. 2003), impaired ATP-induced ROS
formation by 60 ± 30% (Fig.3-7C). In contrast, pre-incubation of cells with 100 µM
apocynin, a specific NADPH oxidase inhibitor (Chen et al. 2003) did not inhibit ATPinduced ROS formation (Fig.3-7D). To determine if the above inhibitors of ROS
formation directly impaired P2X7 function, ATP-induced ethidium+ uptake was
measured in the absence and presence of each inhibitor. None of the above inhibitors
directly affected ATP-induced ethidium+ uptake into MEL cells (Fig.3-8). This indicates
that the observed inhibition of P2X7-induced ROS formation was not due to a direct
action on the receptor.

42

Figure 3-7 Broad spectrum and mitochondrial complex ROS inhibitors impaired P2X7induced ROS formation. H2DCFDA-loaded MEL cells in NaCl medium were preincubated at 37°C in the presence of (A) H2O control or NAC (10 mM, 30 mins), (B)
DMSO control or DPI (20 μM, 30 mins), (C) DMSO control or apocynin (100 μM, 60
mins), (D) DMSO control or rotenone (5 μM, 60 mins), then incubated in the absence
(basal) or presence of 1 mM ATP at 37°C for 15 min. (A-D) Incubations were stopped
by addition of MgCl2 medium and centrifugation, and the cells analysed by flow
cytometry. Results are mean ± SD (A, B n = 3; C, D n = 6); *P < 0.05 and ** P < 0.01
compared to corresponding basal; †† P < 0.01 compared to ATP alone.
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Figure 3-8 ROS formation inhibitors do not impair ATP-induced ethidium+ uptake into
MEL cells. MEL cells were pre-incubated in the absence or presence of ROS inhibitors
as Fig. 3-7. Cells then were incubated with 25 μM ethidium+ in the absence (basal) or
presence of 1 mM ATP at 37°C for 15 min. (A-D) Incubations were stopped by addition
of MgCl2 medium and centrifugation, and the cells analysed by flow cytometry. Results
are mean ± SD (n = 3); **P < 0.01 compared to basal.

44

3.1.8

P2X7-induced reactive oxygen species formation is not dependent on Ca2+influx

A previous study showed that P2X7-induced ROS formation in submandibular cells is
dependent on extracellular Ca2+ (Fontails et.al. 2010). To determine whether P2X7induced ROS formation is dependent on extracellular Ca2+ in MEL cells, cells were
incubated in the absence (control) or presence of 1 mM Ca2+ and ATP. Since free Ca2
lowers the concentration of ATP4-, the form responsible for P2X7 activation (North
2002), cells in the absence or presence of 1 mM Ca2+ were incubated with 1 or 1.74 mM
ATP, respectively, to provide equimolar ATP4- concentrations (251 µM). ATP induced
significant ROS formation in MEL cells incubated in the absence or presence of
additional Ca2+ compared to corresponding MEL cells incubated in the absence of ATP
(Fig.3-9A). Of note, ATP induced ROS formation was slightly but significantly lower in
the presence of Ca2+ (Fig. 3-9A).

To exclude a role for extracellular Ca2+ in P2X7-induced ROS formation, MEL cells
were resuspended in the absence (control) or presence 100 µM EGTA (a Ca2+ chelator),
and then incubated in the absence (basal) and presence of 1 mM ATP. ATP induced a
significant and similar amount of ROS formation in cells incubated in the absence
(control) or presence of EGTA, compared to cells incubated in the absence of ATP (Fig.
3-9B).

To confirm that the failure to find a role for extracellular Ca2+in the P2X7-induced ROS
formation in MEL cells was not due to altered P2X7 function, ATP-induced ethidium+
uptake was assessed in the absence or presence of Ca2+ or EGTA. ATP-induced
ethidium+ uptake was similar in the absence or presence of Ca2+ or EGTA (Fig.3-10).
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However, as for ROS formation, the presence of additional Ca2+ slightly but
significantly impaired ATP induced ethidium+ uptake (Fig. 3-9A).

Figure 3-9 P2X7-induced reactive oxygen species formation is not dependent on Ca2+
influx. H2DCFDA-loaded MEL cells (A) in the absence (control) or presence of 1 mM
Ca2+ in NaCl medium were incubated in the absence (basal) or presence of 1 mM ATP
(251 μM ATP4-) or 1.74 mM ATP (251 μM ATP4-) were incubated at 37°C for 15 min.
(B) H2DCFDA-loaded MEL cells were incubated in NaCl medium in the absence or
presence of 100 μM EGTA in the absence (basal) or presence of 1 ATP mM at 37°C for
15 min. (A,B) Incubations were stopped by addition of MgCl2 medium and
centrifugation, and the cells analysed by flow cytometry. Results are mean ± SD (A, n =
6, B, n = 3); **P < 0.01 compared to corresponding basal; ††P < 0.01 compared to ATP
alone.
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Figure 3-10 Effect of extracellular Ca2+ and EGTA on P2X7-induced ethidium+ uptake
into MEL cells. (A) Cells in the absence (control) or presence of 1 mM Ca2+ in NaCl
medium containing 25 μM ethidium+ were incubated in the absence (basal) or presence
of 1 mM ATP (251 μM ATP4-) or 1.74 mM ATP (251 μM ATP4-), respectively. (B)
Cells in the absence or presence of 100 μM EGTA in NaCl medium containing 25 μM
ethidium+ were incubated in the absence (basal) or presence of 1 mM ATP at 37°C for
15 mins. Incubations were stopped by addition of MgCl2 medium and centrifugation,
and the cells analysed by flow cytometry. Results are mean ± SD (n = 3); **P < 0.01
compared to basal; ††P < 0.01 compared to ATP alone.
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3.1.9

P2X7-induced reactive oxygen species formation is not dependent on K+ efflux

Previous studies have shown that ROS formation is linked to interleukin (IL)-1β release
(Hewinson et al. 2008; Martinon et al. 2009). Moreover, high extracellular K+ was
shown to prevent IL-1β release (Ferrari et al. 1997; Sanz and Virgilio 2000) indicating
that K+ efflux involves in IL-1β release and implicating a role for K+ efflux in ROS
formation as well. Therefore, to determine if P2X7-induced ROS formation is also
dependent on K+ efflux, ATP-induced ROS formation was compared in NaCl medium
and KCl medium. The amounts of ATP-induced ROS formation in MEL cells in KCl
medium were similar to that of cells in NaCl medium (Fig.3-11A). ATP-induced
ethidium+ uptake was similar in cells incubated in either medium (Fig.3-11B).
Collectively, this indicates that P2X7-induced ROS formation is not dependent on K+
efflux from MEL cells.

3.2 Discussion
Our group recently demonstrated that MEL cell line, a model of immature red blood
cells (RBCs), expresses P2X7 receptor, and that activation of this receptor induces rapid
phosphatidylserine (PS) exposure, microparticle release and cell death in this cell line
(Constantinescu 2008). The present study provides the first evidence that P2X7
activation also induces ROS formation in this cell line. In addition, pharmacological
approaches indicated P2X7 activation induced mitochondrial, but not NADPH oxidase
ROS, formation, and this process is not dependent on the Ca2+ influx or K+ efflux.
Collectively, this data indicates that P2X7 activation induces ROS formation in RBCs
via a mechanism different to myeloid and other cell types.
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Figure 3-11 P2X7-induced reactive oxygen species formation is not dependent on K+
efflux. (A) H2DCFDA-loaded MEL cells were incubated in NaCl medium or KCl
medium in the absence or presence of 1 mM ATP at 37°C for 15 mins. (B) Cells in
NaCl medium or KCl medium containing 25 μM ethidium+ were incubated in the
absence (basal) or presence of 1 mM ATP at 37°C for 15 mins. (A, B) Incubations were
stopped by addition of MgCl2 medium and centrifugation, and the cells analysed by
flow cytometry. Results are mean ± SD (n = 3); *P < 0.05, **P < 0.01 compared to
basal.
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P2X7 induces ROS formation in MEL cells. The conclusion is based on several lines of
evidences. First, immunoblotting, immunofluorescence staining (Constantinescu 2008)
and RT-PCR (Fig.3-1) demonstrated P2X7 is present on MEL cells. Secondly,
cytometric measurement demonstrated that ATP-induced ethidium+ and Yo-Pro-12+
uptake (Constantinescu 2008) (Fig.3-2) in MEL cells. Thirdly, Cytofluorometric
measurements of H2DCFDA loaded MEL cells revealed that ATP induces the oxidation
of H2DCFDA to DCF, which directly corresponds to the amounts of ROS formation.
This effect of ATP was time- and concentration-dependent with a maximal response at
2 mM ATP and an EC50 value of ~150 μM (Fig.3-3), which is similar to that of P2X7induced ethidium+ uptake in MEL cells (Constantinescu 2008) and typical type of
recombinant P2X7 (Donnelly-Roberts et al. 2009). Finally, BzATP, but not ADP nor
UTP induced ROS formation into MEL cells (Fig.3-4), again typical of recombinant
P2X7 (Donnelly-Roberts et al. 2009). Finally, ATP-induced ROS formation was
completely impaired by the specific P2X7 antagonist, A-438079 (Nelson et al. 2006)
(Fig.3-5), confirming that the ATP-induced ROS formation in MEL cells is due to P2X7
activation.

P2X7 activation induces ROS formation via a mitochondrial pathway. Mitochondria are
a major site of cellular ROS formation. In contrast, previous studies have reported that
the cell membrane enzyme complex NADPH oxidase, play a dominant role in P2X7induced ROS formation in microglia cells and macrophages (Parvathenani et al. 2003;
Pfeiffer et al. 2007; Noguchi et al. 2008; Moore and MacKenzie 2009). Several
mitochondrial sources of ROS are present along the electron transport chain, including
respiratory complexes I and III (Chen et al. 2003). In the present study, rotenone, a
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specific mitochondrial complex I inhibitor (Chen et al. 2003) significantly impaired
P2X7-induced ROS formation (Fig.4-6C). Moreover, the broad spectrum ROS
formation inhibitor DPI, that inhibits ROS formation of mitochondrial complex I in
murine monocytes/macrophages (Li and Trush 1998), also impaired P2X7-induced
ROS formation (Fig.4-6B). In contrast, apocynin, a specific NADPH oxidase inhibitor,
had no effect on ATP-induced ROS formation (Fig.4-6D), ruling out the involvement of
the NADPH oxidase. Indeed, rotenone also decreased the P2X7-induced ROS
production in murine bone marrow-derived macrophages, but not in J774A.1 cell and
RAW264.7 (Noguchi et al. 2008; Moore and MacKenzie 2009). However in these two
studies, P2X7-induced ROS formation was predominantly inhibited by apocynin, thus it
was concluded that ROS was mainly generated by NADPH oxidase. In contrast, the
present study indicates P2X7-induced ROS formation in murine RBCs is mediated by
mitochondria. Thus, P2X7-induced ROS formation may be mediated by different
pathways in different cell types.

P2X7-induced ROS formation in MEL cells is not dependent on an influx of Ca2+ or
efflux of K+. P2X7 activation is coupled to major changes in the ionic composition of
the cytosol (North 2002; Surprenant and North 2009). Upon activation, P2X7 forms a
non-selective cation channel to cause the influx of Ca2+ and Na+ and an efflux of K+,
leading to various cellular responses (Surprenant and North 2009). P2X7-induced ROS
formation in murine macrophages and rat submandibular cells is dependent on
extracellular Ca2+ (Fontanils et al. 2010; Guadalupe Martel-Gallegos et al. 2010). In
contrast, the present study indicates that P2X7-induced ROS formation in MEL cells
was not significantly altered in the presence of EGTA or Ca2+ (Fig.4-8), excluding a role
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for extracellular Ca2+ in this process. Similarly, P2X7-induced ROS formation in
murine (but not rat) submandibular cells is independent of extracellular Ca2+ (Seil et al.
2008). Thus, the different results indicate that the role of Ca2+ in P2X7-induced ROS
formation is cell type and/or species specific.

The present study also addressed whether K+ efflux is required for P2X7-induced ROS
formation. Previous studies have shown that ROS formation is linked to P2X7-mediated
IL-1β release (Hewinson et al. 2008; Martinon et al. 2009) and high extracellular K+
prevents P2X7-induced IL-1β release (Ferrari et al. 1997; Sanz and Virgilio 2000)
indicating that K+ efflux is involved in IL-1β release. However, the role of K+ effect in
ROS formation during IL-1β release is unknown. In the present study, the amount of
P2X7-induced ROS formation was similar for MEL cells in KCl medium and in the
NaCl medium (Fig.4-10), indicating that P2X7-induced ROS formation is not
dependent on K+ efflux in these cells.

P2X7 mediated-ROS formation has been mainly examined on immune and microgial
cells, where it thought to play a role in microbial killing, inflammation response and cell
death (Guerra et al. 2007). Cellular ROS formation is tightly regulated by various
antioxidant systems, and deficiencies in these systems results in deleterious effects
including tissue damaging (Turrens 2003). RBCs are exposed to high amount of
oxidative-stress during circulation and deficiencies in ROS scavengers indicate that
these cells are particularly vulnerable to excess ROS production (Turrens 2003).
Accumulation of ROS in erythroid cells often results in shortened RBC life span leading
to various anaemias (Çimen 2008; Ghaffari 2008). Thus, given that ROS may
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coordinate RBCs cycle and differentiation, mechanisms of ROS production may
regulate RBC differentiation and life span, P2X7-induced ROS formation in MEL cells
may contribute to these processes in RBC. Although the role of P2X7 in RBC
differentiation and life span has not directly elucidated, our study provides a possible
mechanism by which ROS production is regulated in RBC.
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4 P2X7 INDUCED DEATH OF MURINE ERYTHROLEUKEMIA
CELLS IS DEPENDENT ON CASPASE AND P38 ACTIVATION
4.1 Results
4.1.1

ATP reduces cell numbers of murine erythroleukemia cells

Chatawala and Cantley (1984) originally demonstrated that extracellular ATP impaired
the growth of MEL cells; however the mechanism was not determined. Subsequently
work from our group using cytofluorometric assay reported that ATP induced cell death
of MEL cells, and that this process could be impaired by pre-incubation with the P2X7
antagonist A-438079 (Constantinescu 2008). Therefore, to confirm these observations,
cells were incubated with increasing concentrations of ATP for 24 h and the relative cell
numbers (expressed as absorbances) were measured by thiazolyl blue tetrazolium
bromide (MTT) assay. ATP reduced cell numbers in a concentration-dependent fashion,
with a maximal reduction occurring at 2 mM ATP (Fig. 4-1). ATP at 1 mM reduced of
the cell number by approximately half, compared to cells incubated in the absence of
ATP (basal) (Fig. 4-1).
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Figure 4-1 ATP reduces the cell numbers of MEL cells. MEL cells in complete culture
medium were incubated in the absence (basal) or presence of ATP (as indicated) at
37°C for 24 h. MTT was added during the final 4 h, before overnight incubation with
solubilization solution at 37°C. Absorbances were then read at 550 and 690 nm. Results
are mean absorbance (A550 nm−A690 nm) ± SD (n = 3); ** P < 0.01 compared to
corresponding basal.

4.1.2

A P2X7 antagonist prevents the ATP-induced reduction numbers of murine
erthroleukemia cell

To determine if the ATP-reduced number of MEL cells was mediated by P2X7
activation, cells were pre-incubated in the absences (control) or presence of the specific
P2X7 antagonist, A-438079 (Nelson et al. 2006), before overnight incubation in the
absences (control) or presence of 1 mM ATP. As above, incubation with ATP reduced
numbers of MEL cells (Fig. 4-2). Pre-incubation of 10 µM A-438079 impaired the
ATP-induced reduction of cell number by 94 ± 3%, compared to cells incubated with
ATP along (Fig.4-2)
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Figure 4-2 A P2X7 antagonist prevents the reduction of numbers of MEL cells by ATP.
MEL cells in complete culture medium were pre-incubated in the absence (control) or
presence of 10 µM A-438079 at 37°C for 15 min. Cells were then incubated in the
absence (basal) or presence of 1 mM ATP at 37°C for 24 h. MTT was added during the
final 4 h, before overnight incubation with solubilization solution at 37°C. Absorbances
were then read at 550 and 690 nm. Results are mean absorbance (A550 nm−A690 nm) ± SD
(n = 3); ** P < 0.01 compared to corresponding basal; †† P < 0.01 compared to ATP
alone.

4.1.3

ATP induces the death of murine erthroleukemia cells

To further confirm the study of Constantinescu (2008), MEL cells were incubated with
in the absence or presence of 1 mM ATP for 24 h, and the amount of cell death was
determined by flow cytometry using Annexin-V binding (Phosphatidylserine or PS
exposure) and 7-aminoactinomycin D (7AAD) uptake (loss of plasma membrane
integrity) (Fig. 4-3A). Incubation with ATP induced an approximately 5.7-fold increase
in Annexin-V+ and 7AAD+ cells, compared to cells incubated in the absence of ATP
(Fig. 4-3B). These double positive cells represent either necrotic or late apoptotic cells,
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or a combination of both (Kroemer et al. 2005). Incubation with ATP resulted in an
approximately 3.4-fold and 6.2-fold increase in Annexin-V+/7AAD− (early apoptotic)
cells and Annexin-V−/7AAD+ (necrotic) cells respectively, compared to cells incubated
in the absence of ATP (Fig. 4-3B).
4.1.4

A P2X7 antagonist impairs ATP-induced cell death

To confirm that the ATP-induced MEL cell death was via P2X7 activation as reported
previously (Constantinescu 2008), cells were pre-incubated in the absence (control) or
presence of A-438079, before overnight incubation in the absence (basal) or presence of
1 mM ATP. ATP failed to induce a significant increase in Annexin-V-/7AAD+ cells (Fig.
4-4B). This inconsistent ability of ATP to induce an increase in Annexin-V-/7AAD+
cells MEL cells has also been previously observed (Constantinescu 2008). The ability of
ATP to induce necrotic cells (in Annexin-V-/7AAD+) was also variable in subsequent
experiments (below) (data not shown). Therefore, the effect of ATP and other
treatments on this dead cell population is not reported further. As above (Fig. 4-3),
however, incubation with ATP induced a significant increase in Annexin-V+/7AAD- and
Annexin-V+/7AAD+ cells, compared to cells incubated in the absence of ATP (Fig. 44A, C). Pre-incubation with A-438079 significantly impaired the ATP-induced increase
of Annexin-V+/7AAD- and Annexin-V+/7AAD+ cells by 88 ± 6% and 78 ± 15%,
respectively (Fig. 4-4B, C). Pre-incubation with A-438079 did not alter the basal and
ATP-induced cell death.
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Figure 4-3 ATP induces the death of MEL cells. (A, B) MEL cells in complete culture
medium were incubated in the absence (basal) or presence of 1 mM ATP at 37°C for 24
h. Cells were harvested, incubated with Annexin-V-FLUOS and 7AAD, and analysed
by flow cytometry. (A) (Top panels) Representative dot plots showing the forward and
side scatter of cells; (bottom panels) representative dot plots showing (lower left
quadrat) viable Annexin-V−/7AAD− cells, (lower right quadrant) Annexin-V+/7AADcells representing early apoptotic cells, (upper left quadrant) Annexin-V−/7AAD+ cells
representing necrotic cells and (upper right quadrant) Annexin-V+/7AAD+ cells
representing either necrotic or late apoptotic cells or a combination of both. (B) Results
expressed as mean percentage of cells ± SD (n = 3); **P < 0.01 compared to
corresponding basal.
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Figure 4-4 A P2X7 antagonist impairs ATP-induced death of MEL cells. MEL cells in
complete culture medium were pre-incubated in the absence (control) or presence of 10
µM A-438079 at 37°C for 15 min. Cells then were incubated in the absence (basal) or
presence of 1 mM ATP at 37°C for 24 h. Cells were harvested, incubated with AnnexinV-FLUOS and 7AAD, and analysed by flow cytometry. Cells were defined as (A)
necrotic (Annexin-V−/7AAD+) (B) early apoptotic (Annexin-V+/7AAD-) or (C) late
apoptotic/necrotic (Annexin-V+/7AAD+). Results expressed as mean ± SD (n = 3); **P
< 0.01 compared to corresponding basal. †† P < 0.01 compared to ATP alone.
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4.1.5

Murine erthroleukemia cells following P2X7 activation are phagocytosed by
J774A.1 macrophages

Dead RBCs are removed from the circulation by phagocytic cells of the spleen and
liver. (Foeller et al. 2008). However, it is currently unknown if dead cells, as a result of
P2X7 activation, can be phagocytosed by macrophages. Therefore, MEL cells were
labelled with membrane dye, PKH-26, as described (Healey et al. 2007). Then, PKH-26
labelled MEL cells were incubated in the absence or presence of 1 mM ATP for 24 h
and co-cultured with the macrophage-like cell line J774A.1 cells for 1 h and the amount
of phagocytosis determined by flow cytometry as described (Schrijvers et al. 2004).
J774A.1 cells incubated without MEL cells were used to determine the background
fluorescence of these cells (Fig.4-5A, D). Co-incubation of macrophages with MEL
cells (pre-incubated in the absence of ATP; control) resulted in phagocytosis with 26 ±
1% of macrophages containing PKH-26 labelled MEL cells (Fig.4-5B, E). Coincubation of macrophages with MEL cells (pre-incubated with ATP) showed a slightly
but significantly higher amount of phagocytosis with 31 ± 1% of macrophages
containing PKH-26 labelled MEL cells (Fig.4-5C, F), compared to control.

To determine if this slightly but significantly higher increase in phagocytosis of MEL
cells following ATP incubation was due to P2X7 activation, MEL cells were preincubated with 10 µM A-438079 prior to the addition of ATP and the amount of
phagocytosis determined as described above. As above, pre-incubation of ATP induced
a slight but significant amount of phagocytosis, compare to control MEL cells (Fig.4-6).
Pre-incubation of MEL cells with A-438079 did not affect the phagocytosis of MEL
cells incubated without ATP (Fig.4-6). In contrast, pre-incubation of MEL cells with 10
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µM A-438079 prior to the addition of ATP prevented the amount of phagocytosis of
ATP treated cells by 82 ± 2%, compared to phagocytosis of ATP-treated MEL cells not
pre-incubated with A-438079 (Fig.4-6).

Figure 4-5 ATP-treated MEL cells are phagoctytosed by J774A.1 macrophages. PKH26 labelled MEL cells in complete culture medium were incubated in the absence
(control) or presence of 1 mM ATP at 37°C for 24 h. MEL cells were then incubated
with J774A.1 cells at 37°C for 1 h. Followed incubation, cells were washed with cold
PBS and treated with 0.05% trypsin for 5 min to remove non-phagocytosed MEL cells.
Finally, adheret cells were harvested by scraping and analysed by flow cytometry. (AC) Representative forward and side scatter dot plots of J774A.1 cells incubated with (A)
complete culture medium alone, (B) control MEL cells or (C) ATP treated MEL cells.
(A-C) The gating strategy shown was used to gate J774 cells only (gate 1), and to
exclude MEL cells (gate 2) and debris. (D-F) Representative dot plot representing the
proportion of macrophages positive for PHK-26 staining. Gate 3 was used to determine
the percentage of PKH-26 positive J774A.1 macrophages. Percentages are expressed as
mean ± SD (n = 3) and representative dot plots of each are shown.
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Figure 4-6 Pre-treatment of MEL cells with a P2X7 antagonist prevented phagocytosis
of ATP-treated MEL cells by J774A.1 macrophages. PKH-26 labelled MEL cells in
complete culture medium were pre-incubated in the absence (control) or presence of 10
µM A-438079 at 37°C for 15 min. Cells then were incubated in the absence (basal) or
presence of 1 mM ATP at 37°C for 24 h. MEL cells were then incubated with J774A.1
cells at 37°C for 1 h. Followed incubation, cells were washed with cold PBS and treated
with 0.05% trypsin for 5 min to remove non-phagocytosed MEL cells. Finally, adherent
cells were harvest by scraping and analysed by flow cytometry. Results expressed as
mean percentage ± SD (n=3); * P < 0.05 compared to corresponding basal. † P < 0.05
compared to ATP alone.

4.1.6

P2X7-induced death of murine erthroleukemia cells requires the activity of
caspase

Activation of caspases plays a central role in apoptosis (Riedl and Shi 2004). Moreover,
P2X7-induced macrophages apoptosis involves caspase activation (Ferrari et al. 1999;
Wang et al. 2004; Kong et al. 2005; Noguchi et al. 2008; Fu et al. 2009). Therefore, to
determine the role of caspase activation in P2X7-induced MEL cell death, cells were
incubated in the presence of DMSO control or broad spectrum caspase inhibitor Z62

VAD-FMK (20 µM) (Nogchi et al. 2008) prior to addition of ATP. As shown (Section
4.1.4), incubation of ATP induced a significant increase in Annexin-V+/7AAD− and
Annexin-V+/7AAD+ cells (Fig. 4-7A, B). Pre-incubation of cells with Z-VAD-FMK
failed to impair the ATP-induced increase of Annexin-V+/7AAD- cells (Fig. 4-7A). In
contrast, Z-VAD-FMK significantly impaired ATP-induced increase of AnnexinV+/7AAD+ cells by 36 ± 2% (Fig. 4-8B). Pre-incubation of cells in presence or DMSO
and Z-VAD-FMK also did not alter basal cell death (Fig. 4-8A, B). This suggests
blockage of caspase activity impairs the ability of MEL cells to undergo late apoptosis
or necrosis following P2X7 activation, and indicates a role for this enzymes family in
P2X7-induced death of MEL cells.
A previous study reported that pre-incubation with Z-VAD-FMK blocked P2X7mediated pore formation in human THP-1 cells (Donnelly-Roberts et al. 2004). To
exclude the possibility that Z-VAD-FMK impaired ATP-induced death of MEL cells by
directly inhibiting P2X7 function rather than casapase activity, cells were pre-incubated
in the presence of DMSO control or Z-VAD-FMK, and the ATP-induced ethidium+
uptake measured. ATP-induced ethidium+ uptake into MEL cells was similar following
pre-incubation with DMSO or Z-VAD-FMK (Fig. 4-8).

4.1.7

P2X7 stimulates caspase activation in MEL cells

To examine if ATP stimulates caspase activation in MEL cells, a cytoflurometric
caspase activation assay was performed. This assay utilizes the caspase family inhibitor
VAD-FMK conjugated to fluoresceinisothiocyanate (FITC) as a measure of activated
caspases in cells. Following incubation in the absence (basal) or presence of 1 mM ATP
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for 6 h, MEL cells were incubated with FITC-VAD-FMK for 1 h and caspase activation
was measured by flow cytometry. Incubation of cells with ATP resulted in
approximately a 2.5-fold increase in the relative percentage of cells with activated
caspases, compared to cells incubated in the absence of ATP (23 ± 3% and 9 ± 1%,
respectively, n = 3, p < 0.01; Fig. 4-9A).

Figure 4-7 A broad spectrum caspase inhibitor impairs P2X7-induced MEL cell death.
MEL cells in complete culture medium were pre-incubated in the presence of DMSO or
20 µM Z-VAD-FMK at 37°C for 30 min, and then incubated in the absence (basal) or
presence of 1 mM ATP at 37°C for 24 h. Cells were harvested, and incubated with
Annexin-V-FLUOS and 7AAD, and analysed by flow cytometry. Cells were defined as
(A) early apoptotic (Annexin-V+/7AAD-) or (B) late apoptotic/necrotic (AnnexinV+/7AAD+). Results are mean ± SD (n = 3); **P < 0.01 compared to corresponding
basal; ††P < 0.01 compared to ATP with DMSO.
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Figure 4-8 A broad spectrum caspase inhibitor does not affect P2X7-induced ethidium+
uptake into MEL cells. MEL cells in NaCl medium were pre-incubated in the presence
of DMSO or 20 µM Z-VAD-FMK at 37°C for 30 min, then 25 μM ethidium+ was added,
and cells were incubated in the absence (basal) or presence of 1 mM ATP at 37°C for 15
min. Incubations were stopped by addition of MgCl2 medium and centrifugation, and
the cells analysed by flow cytometry. Results are mean ± SD (n = 3); **P < 0.01
compared to basal.

To determine if ATP-induced caspase activation in MEL cells was the result of P2X7
activation. Cells were pre-incubated in the absence (control) and presence of 10 µM A438079. As above, ATP induced caspase activity in MEL cells (Fig. 4-9B). In contrast,
pre-incubation with A-438079 impaired the ATP-induced increase in the percentage of
caspase activated cells by 99 ± 13% (Fig. 4-9B). The percentage of caspase-activated
cells in the absence or presence of A-438079 without ATP was similar (Fig. 4-9B).
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Figure 4-9 P2X7 induces caspase activation in MEL cells. (A, B) MEL cells in
complete culture media were incubated in the absence (basal) or presence of 1 mM ATP
at 37°C for 6 h. (B) MEL cells were pre-incubated in the absence or presence of 10 µM
A-438079 prior to the addition of ATP. Cells were harvested, and incubated with FITCVAD-FMK at 37°C for 1 h, and analysed by flow cytometry. (A) Representative
histogram showing relative caspase activity in basal cells (shaded) and ATP treated cells
(solid line). A marker region (as shown) was used to determine the percentage of cells
with activated caspase. (B) results expressed as mean percentage ± SD (n = 3); ** P <
0.01 compared to corresponding basal. †† P < 0.01 compared to ATP alone.
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4.1.8

P2X7-induced MEL cell death requires the activity of mitogen-activated protein
kinase p38

A previous study has reported that P2X7-induced macrophage death is dependent on
mitogen-activated protein kinase (MAPK) p38 activation (Noguchi et al. 2008).
Therefore, to determine if P2X7-induced MEL cell death requires the activation of p38
MAPK, cells were incubated in the presence of DMSO control or the p38 inhibitors,
SB202190 or SB203580 (Noguchi et al. 2008) prior to incubation in the absence (basal)
or presence of ATP. As shown above (Section 4.1.4 and 4.1.6), incubation of ATP
induced a significant increase in Annexin-V+/7AAD− and Annexin-V+ /7AAD+ cells
(Fig. 4-10A, B). Pre-incubation of cells with 20 µM SB202190 significantly impaired
the ATP-induced increase of Annexin-V+/7AAD- cells and Annexin-V+/7AAD+ cells by
56 ± 5% and 56 ± 9%, respectively (Fig. 4-10A, B). Similarly, pre-incubation of MEL
cells with SB203580 impaired the ATP-induced increase of Annexin-V+/7AAD- cells
and Annexin-V+/7AAD+ by 52 ± 6% and 48 ± 17%, respectively (Fig. 4-10C, D).
Incubation in the absence or presence of each p38 MAPK inhibitors did not alter basal
cell death (Fig. 4-10).

As for Z-VAD-FMK, both SB202190 or SB203580 (20 µM) can block P2X7-mediated
pore formation in human THP-1 cells (Donnelly-Roberts et al. 2004). Thus, to
determine if either of these p38 MAPK inhibitors directly impaired P2X7 function in
MEL cells, cell was pre-incubated in the presence of DMSO, or SB202190 or
SB203580, and the P2X7-induced ethidium+ uptake accessed. Neither of these
inhibitors affected ATP-induced ethidium+ uptake into MELs (Fig. 4-11A, B).
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Figure 4-10 p38 MAPK inhibitors impair P2X7-induced MEL cell death. MEL cells in
complete culture medium were pre-incubated in the presence of (A-D) DMSO, (A, B)
20 µM SB202190 or (C, D) 20 µM SB203580 at 37°C for 30 min. (A-D) Cells then
were incubated in the absence (basal) or presence of 1 mM ATP at 37°C for 24 h. Cells
were harvested, and incubated with Annexin-V-FLUOS and 7AAD, and analysed by
flow cytometry. Cells were defined as (A) early apoptotic (Annexin-V+/7AAD-) or (B)
late apoptotic/necrotic (Annexin-V+/7AAD+). Results are mean ± SD (n = 3); * P <
0.05, **P < 0.01 compared to corresponding basal; †P< 0.05, ††P< 0.01 compared to
ATP alone.
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Figure 4-11 p38 MAPK inhibitors did not alter ATP-induced ethidium+ uptake into
MEL cells. MEL cells in NaCl medium were pre-incubated in the (A, B) presence of
DMSO, (A) 20 µM SB202190 or (B) 20 µM SB203580 at 37°C for 30 min. (A, B)
Then 25 μM ethidium+ was added and cell were incubated at 37°C for 15 min in the
absence (basal) or presence of 1 mM ATP. Incubations were stopped by addition of
MgCl2 medium and centrifugation, and the cells analysed by flow cytometry. Results
are mean ± SD (n = 3); **P < 0.01 compared to corresponding basal
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4.1.9 P2X7 stimulates p38 activation in murine erthroleukemia cells
To further support the role of p38 MAPK activation in the P2X7-induced cell death of
MEL, immunoblotting phospholylated p38 MAPK was performed as a measure of p38
MAPK activation. Immunoblotting of total p38 was used as a loading control.
Immunoblotting with an anti-phospho-p38 MAPK antibody revealed that ATP at 1 mM
induced considerable p38 MAPK phospholylation, compared to cells incubated in the
absence of ATP (5 min) (Fig. 4-12). Pre-incubation of cells with 10 µM A-438079
before

the

incubation

with

ATP

significantly

impaired

ATP-induced

p38

phospholylation compared to ATP alone (Fig.4-12). Pre-incubation of cells with A438079 alone induced a small amount of p38 MAPK phospholylation, compared to cells
incubated in the absence of A-438079 and ATP (Fig. 4-12).

Figure 4-12 P2X7 induces activation of p38 MAPK. MEL cells in complete medium
were pre-incubated in the absence and presence of 10 µM A-438079 at 37°C for 15 min,
and then incubated in the absence and presence of 1 mM ATP at 37°C for 5 min.
Incubation was stopped by addition of complete medium and centrifugation. Whole cell
lysates of MEL cells were separated by electrophoresis, transferred to nitrocellulose
membrane and probed with phospho-p38 antibody and anti-p38 antibody.
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Figure 4-13 Effects of ROS inhibitors on P2X7-induced cell death in MEL cells. MEL
cells in complete culture medium were pre-incubated in the presence of (A, B) H2O
control or 10 mM NAC, or (B) in the presence of DMSO control and 10µM DPI at
37°C for 30 min. (A-D) cells were then incubated in the absence (basal) or presence of 1
mM ATP at 37°C for 24 h. Cells were harvested, and incubated with Annexin-VFLUOS and 7AAD, and analysed by flow cytometry. Results are mean ± SD (n = 3); *
P<0.05, ** P < 0.01 compared to corresponding basal, †† P < 0.01 compared to ATP
alone, ‡‡ P < 0.01 compared to basal alone.
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4.1.10 P2X7-induced cell death is independent on reactive oxygen species formation
Several groups have reported that P2X7-induced macrophages death is dependent on
ROS formation via the activity of NADPH oxidase (Harada et al. 2003; Noguchi et al.
2008; Moore and MacKenzie 2009). To explore the role of ROS formation in P2X7induced cell death in MEL cells, cells were pre-incubated in the absence and presence
of

the

broad

spectrum

ROS

inhibitors

N-acetyl-L-cysteine

(NAC)

and

diphenyleneiodonium (DPI) before incubation cells in the absence (basal) and presence
of ATP. As above, ATP induced a significant increase in Annexin+/7AAD- and
Annexin+/7AAD+ cells. Pre-incubation of cells with NAC did not impair P2X7 induced
MEL cell death (Fig. 4-13A, B). Pre-incubation of cells in the absence or presence of
NAC alone did not significantly alter basal cell death (Fig. 4-13A, B). In contrast, the
effect of DPI on P2X7-induced cells death could not be fully assessed due to the high
amount of cell death induced by DPI alone and in the presence of ATP (Fig. 4-13C, D).
In fact, incubation of cells with DPI in the presence of ATP induced nearly 100% cell
death (Fig. 4-13C, D).

4.2 Discussion
Chatawala and Cantley (1984) originally showed that extracellular ATP impaired the
growth of MEL cells. Subsequently work from our group using a cytofluorometric assay
involving Annexin-V binding and 7AAD staining demonstrated that P2X7 activation
induced MEL cell death (Constantinescu 2008). The aims of this study were to confirm
that P2X7 activation induces MEL cell death and to determine the signalling pathways
involved in this process. Using an MTT assay, as well as the same cytofluorometric
assay as Constantinescu (2008), ATP was shown to induce cell death and these
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processes were blocked by P2X7 antagonist A-438079 (Nelson et al. 2005), confirming
the role of P2X7 in this process. Moreover, following P2X7 activation, MEL cells were
phagocytosed by J774A.1 macrophages, providing another indicator of cell death
(Krysko et al. 2008). Finally, the current study demonstrates that P2X7-induced cell
death involves the activation of the p38 MAPK and caspase, but not ROS formation.

MTT assay indirectly demonstrated that P2X7 activation induces the death of MEL
cells (Fig. 4-1, 2). The MTT assay is a relatively inexpensive and convenient method to
measure cell proliferation or cell death. However, this assay measures the cellular
metabolic activity rather than cell numbers directly, and does not distinguish between
increased cell death or impaired cell number. Nevertheless, this assay provides indirect
evidences that P2X7 activation induces MEL cell death and parallels the earlier
observations where ATP impaired MEL cell growth (Chatawala and Cantley 1984).
Moreover, this assay determined that ATP induced-cell death is in a concentrationdependent fashion, with cell death maximal at 2 mM, and ATP at 1 mM induced about
50% cell death, compared to basal (Fig. 4-1). Thus, 1 mM ATP was selected for
subsequent studies to investigate the signaling pathway involving in P2X7-induced
MEL cell death.

Cytofluorometric analysis of PS exposure cells using Annexin-V and lost in membrane
integrity using 7AAD revealed that P2X7 activation results in MEL cell apoptosis.
However, whether this cell death represents apoptosis or necrosis, or both cannot be
exclusively determined by using only these two markers of cell death (Kroemer et al.
2005). Nevertheless, the consistent increase in Annexin-V+/7AAD- (early apoptosis)
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cells and Annexin-V+/7AAD+ (late apoptosis/necrosis) cells (Fig. 4-3, 4) is consisted
with study of Constantinescu (2008), and favours the idea that P2X7 activation induces
apoptosis rather than necrosis of MEL cells.

The phagocytosis of MEL cells by J774A.1 macrophages is enhanced by following
P2X7 activation in MEL cells. Healey et al (2007) have used a flow cytometric assay to
measure the phagocytosis of aged sheep erythrocytes by THP-1 monocytes in vitro.
While Schrijvers et al. (2009) have also used a flow cytometic assay to measure the
phagocytosis of fluorescent beads or apoptotic monocytes by J774A.1 macrophages in
vitro. Using a combination of these conditions, PKH-26-labelled MEL cells were
incubated in the presence or absence of ATP for 24 h, co-cultured with J774A.1
macrophages for 1 h and the relative phagocytosis of MEL cells were assessed. The
results in this study demonstrated that ~25% J774A.1 macrophages phagocytosed
untreated MEL cell, and that the amount of phagocytosis of P2X7 activated MEL cells
was only slightly greater (Fig.4-5, 6). The relatively high amount of phagocytosis of
untreated MEL cells by J774A.1 macrophages was unexpected and not consistent with
other studies using fluorescent beads or apoptotic monocytes (Schrijvers et al. 2004).
Moreover, the small but significant difference between the phagocytosis of untreated
and P2X7 activated-MEL cells is disproportionate to the amount of cell death observed
above. One possible explanation is that the PBS washing and 0.05% trypsin treatment to
remove non-phagocytosed MEL cells adhering to macrophages was not totally
effective. Hypotonic lysis of non-phagocytosed MEL cells may minimize this effect.
Alternatively, the relative amount of P2X7 activation and subsequent cell death may
have been too low to see an effect. Collectively, the present study suggests that the
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phagocytosis of MEL cells by J774A.1 macrohages may be a useful model for further
studying phagocytosis of P2X7-activated MEL cells and other RBCs by macrophages,
but future refinement of this procedure needs to be undertaken as described above.

The process by which senescent erythrocytes, after their 120 day lifespan, are
recognised and removed by macrophages of the spleen and liver is poorly understood
but is important for balancing the total number of circulating RBCs. PS exposure is one
of the signals that allow macrophages to bind and ingest dying cells, including
senescent RBCs (Foeller et al. 2008; Lang et al. 2008). P2X7 induces cell death in a
variety of cell types, however, the physiological role of this process in RBCs and other
cell types is barely known. Studies of P2X7-deficient mice suggest that the P2X7 is not
involved in regulating cell numbers under normal, physiological conditions (Labasi et
al. 2002; Chessell et al. 2005), except in bone homeostasis (Ke et al. 2003), while
impaired P2X7-induced cell death may promote epithelial malignancies, suggesting a
role for P2X7 activation regulating epithelial cell growth under some circumstances
(Gorodeski 2009). Thus, given the role of P2X7 in mediating MEL cells cell death and
their subsequent phagocytosis revealed by the present study, it is reasonable to
hypothesise that P2X7 activation may play a role in removing senescent, damaged or
diseased RBCs from the circulation.

P2X7-induced cell death of MEL cells is mediated by caspase activation. Pre-incubation
of MEL cells with the broad spectrum caspase inhibitor Z-VAD-FMK impaired
Annexin-V+/7AAD+ cells (late apoptotic / necrotic cells), but not Annexin-V+/7AADcells (early apoptotic cells), following P2X7 activation (Fig. 4-6). This observation
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however suggests that inhibition of caspases in MEL cells does not completely impair
cell death, but only delays this process. To further determine the role of caspase in
P2X7 induced early apoptotic events in MEL cells, studies should include examination
of the effect of Z-VAD-FMK on ATP induced DNA fragmentation, which is typical
event in early apoptosis. Nevertheless, the detection of P2X7-induced caspase activation
in MEL cells (Fig. 4-9) support a role for caspase in P2X7-induced MEL cell death.
Caspase activation plays a central role in the execution of apoptosis by causing nuclear
condensation, DNA fragmentation and other apoptotic changes (Riedl and Shi 2004).
Previous studies reported that caspase activation in macrophages, microglia and neural
cells plays an important role in P2X7 induced cell death (Ferrari et al. 1999; Humphreys
et al. 2000; Kong et al. 2005; Noguchi et al. 2008) . Although the specific caspase was
(were) not identified, this result is consistent with others.

P2X7 induced cell death can be mediated by p38 MAPK pathway in MEL cells. Preincubation of MEL cells with p38 inhibitors impair P2X7-induced cell death (Fig. 4-10),
and that P2X7-induced p38 activation was subsequently indentified (Fig. 4-12),
supporting the role of p38 activation in MEL cell death. MAPK p38 activation was
shown to mediated P2X7-induced death of macrophages(Noguchi et al. 2008). The
present results are consistent with previous study .
Finally, the present study indicates that ROS formation does not mediate P2X7-induced
MEL cell death. Incubation of MEL cells with the ROS inhibitors NAC did not prevent
the P2X7-induced MEL death (Fig. 4-13), despite these inhibitors impairing P2X7induced ROS formation in MEL cells (Chapter 3). Previous studies have indicated that
ROS formation generating from NADPH oxidase plays an important role in P2X776

induced death of macrophages (Noguchi et al. 2008) (Moore and MacKenzie 2007). In
contrast, my study showed that P2X7 induced mitochondrial ROS formation in MEL
cells rather than NADPH oxidase. This result is different from that the role of ROS in
other myeloid cells. The relation of P2X7-induced ROS formation and cell death
pathways will be further discussed in the General Discussion (Chapter 5).
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5 GENERAL DISCUSSION AND CONCLUSIONS
P2X7 activation induces a variety of downstream effects including reactive oxygen
species formation (ROS) and cell death (Sluyter and Stokes 2011). The P2X7-induced
ROS formation is mainly documented in macrophages and microglia cells, where it
plays a role in microbial killing, inflammation response and cell death (Hewinson and
Mackenzie 2007). One topic of this thesis was to determine whether P2X7 induces ROS
formation in an immature red blood cell (RBC) model, murine erythroleukemia (MEL)
cell line. The present study confirmed that MEL cells express functional P2X7. Various
species RBCs express P2X7 receptor, however, the role of P2X7 on RBCs is barely
known. The presence of functional P2X7 in MEL cells substantiates the presence of
this receptor in erythroid cells and provides a model to further elucidate the role of
P2X7 in RBCs. The present study also demonstrates that P2X7 activation induces ROS
formation via the mitochondrial pathway in MEL cells (Fig. 5-1). Previous studies have
identified NADPH oxidase as the source of P2X7-induced ROS formation in
macrophages and microglia cells (Parvathenani et al. 2003; Noguchi et al. 2008).
However, to date there has been little evidence for a role for P2X7 in mitochondrial
ROS formation or for P2X7-induced ROS formation in RBCs.

The other major topic of this thesis was to determine the mechanism of P2X7-induced
cell death. Chatawala and Cantley (1984) originally showed that extracellular ATP
impaired the growth of MEL cells; however the mechanism was not determined. Work
from our group demonstrated that P2X7 activation induces death of MEL cells
(Constantinescu 2008). The present study demonstrates that P2X7-induced death of
MEL cell involves the activation of mitogen-activated protein kinase (MAPK) family
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member p38 and caspase but not ROS formation (Fig. 5-1). Moreover, MEL cells
following P2X7 activation can be phagocytosed by J774A.1 macrophages.

Figure 5-1 Proposed mechanisms of P2X7-induced ROS formation and death in MEL
cells. (Left) Activation of P2X7 by extracellular ATP induces mitochondrial ROS
formation, possibly by enhancing the intramitochondial Ca2+ load. (Right) P2X7induced cell death involves activation of p38 MAPK and caspase, but not ROS
formation. Whether p38 MAPK is upstream of caspase activation, or belong to a
separated pathway from caspase remains unknown.

The mechanism of P2X7-induced ROS formation and cell death revealed in MEL cells
is different from that of macrophages. Several groups have reported that P2X7-induced
ROS formation is via the activation of NADPH oxidase in macrophages and microglia
cells (Harada et al. 2003; Noguchi et al. 2008; Moore and MacKenzie 2009). In one of
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these studies (Noguchi et al. 2008), P2X7-induced ROS formation was found to
mediate P2X7-induced cell death. However, the current study indicates that P2X7induced death in MEL cells is independent on ROS formation. The different results also
indirectly support that P2X7 induces ROS formation in MEL cells uses a different
mechanism from that in macrophages, namely the mitochondria versus NADPH oxidase
respectively.

Future study is needed to confirm the role of mitochondria in the P2X7-induced ROS
formation in MEL cells. Mitochondrial ROS-sensitive probes, such as Mitosox red
superoxide indicator, could be used to directly confirm mitochondrial ROS formation
following P2X7 activation. Although the current study exclude a role of extracellular
Ca2+ and an influx of Ca2+ across the plasma membrane in P2X7-induced ROS
formation in MEL cells, this pathway still may involve intracellular Ca2+. Study of
P2X7-transfected cells showed that intramitochondrial Ca2+ is at least twice higher than
control cells (Adinolfi et al. 2005; Di Virgilio et al. 2009). Given that P2X7 activation
can enhance the flux of Ca2+ into mitochondria, and this increased mitochondrial Ca2+
can lead to increased ROS formation (Brookes et al. 2004; Feissner et al.2009), it will
be of interest to further investigate whether intracellular Ca2+ plays a role in the P2X7
induced mitochondria pathway of ROS formation in MEL cells. BAPTA-AM, an
intracellular Ca2+ chelator, could be used to assess the role of intracellular Ca2+ in this
process.

The present study also showed inhibitors of p38 MAPK and caspase only partially
impaired P2X7-induced cell death. Thus, it is possible that P2X7 induced MEL cell
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death may involve other signalling molecules or pathways. Moreover, as described (Fig.
5-1), p38 MAPK activation may up-regulates the caspase activity, which could be
assessed by directly examining the effect of p38 MAPK inhibitors on ATP-induced
caspase activation in MEL cells. Future experiments could also include the use of
caspase specific inhibitors, as well as caspase specific cytofluorometric or
immunoblotting assays determine which caspase family member are responsible for
P2X7 induced MEL cell death. The most likely candidates would be caspase-1, -3, -8
and/or 9.

Finally, to confirm the process of MEL cells phagocytosed by J774A.1 macrophages
following P2X7 activation, it appears necessary to incubate MEL cells with a maximal
concentration of ATP (2 mM) to induce maximal cell death, and increase the difference
in phagocytosis between untreated and ATP-treated MEL cells. Recently, a role for
ATP and purinergic receptor activation on macrophages has been shown to enhance the
phagocytosis of dying cells (Marques-da-Silva et al.). However, it appears unlikely that
the exogenous ATP added to MEL cells contributed to their enhanced phagocytises, as
MEL cells were extensively washed prior to incubation with J774A.1 macrophages.
However, a role for ATP released from dying MEL cells contributing to enhanced
phagocytosis cannot be excluded. Thus, future phagocytosis assays with MEL and
J774A.1 cells should be conducted in the presence of P2X antagonists and/or apyrase.

The role of mitochondria in P2X7-induced ROS formation revealed by the present study
raises questions about the role of P2X7 in mature RBCs, which lack of mitochondria
and nucleus. Whether P2X7 activation can mediate ROS formation in mature RBCs
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remain unknown. In contrast, the absence for mitochondrial ROS formation in P2X7induced death of MEL cells suggests that the same pathway, involving p38 MAPK and
caspase, may be also operated in mature RBCs. Future studies on primary erythrocytes
are required to address and confirm the role of P2X7 in mature RBCs.

In conclusion, the present study provides first evidence that P2X7 induces ROS
formation in MEL cells, and that this process occurs via mitochondrial pathway. This
study also demonstrates that MEL cells following P2X7 activation can be phagocytosed
by macrophages. Finally, P2X7 induced cell death is dependent on p38 and caspase
activation, but not ROS formation. Future studies of MEL cells and primary RBC cells
will help to further understand the roles of the P2X7 receptor in RBC development and
lifespan, and disease.
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